Optical dosimetry tools and Monte Carlo based methods for applications in image guided optical therapy in the brain by Verleker, Akshay N Prabhu
Purdue University
Purdue e-Pubs
Open Access Dissertations Theses and Dissertations
8-2016
Optical dosimetry tools and Monte Carlo based
methods for applications in image guided optical
therapy in the brain
Akshay N Prabhu Verleker
Purdue University
Follow this and additional works at: https://docs.lib.purdue.edu/open_access_dissertations
Part of the Biomedical Engineering and Bioengineering Commons, and the Medicine and Health
Sciences Commons
This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.
Recommended Citation
Verleker, Akshay N Prabhu, "Optical dosimetry tools and Monte Carlo based methods for applications in image guided optical therapy







This is to certify that the thesis/dissertation prepared
By  
Entitled
For the degree of 
Is approved by the final examining committee: 
To the best of my knowledge and as understood by the student in the Thesis/Dissertation 
Agreement, Publication Delay, and Certification Disclaimer (Graduate School Form 32), 
this thesis/dissertation adheres to the provisions of Purdue University’s “Policy of 
Integrity in Research” and the use of copyright material.
Approved by Major Professor(s): 
Approved by:
Head of the Departmental Graduate Program Date
Akshay N Prabhu Verleker
OPTICAL DOSIMETRY TOOLS AND MONTE CARLO BASED METHODS FOR APPLICATIONS IN IMAGE GUIDED
OPTICAL THERAPY IN THE BRAIN
Doctor of Philosophy










OPTICAL DOSIMETRY TOOLS AND MONTE CARLO BASED METHODS FOR APPLICATIONS 
IN IMAGE GUIDED OPTICAL THERAPY IN THE BRAIN 
A Dissertation 




Akshay N Prabhu Verleker  
In Partial Fulfillment of the 
Requirements for the Degree 
of 
Doctor of Philosophy 
August 2016  
Purdue University 









I am profoundly grateful to my PhD adviser Dr. Keith Stantz, for his support and for the 
opportunity to work on fresh ideas in the field of Biomedical Optics. I am thankful to my 
Graduate Committee Members Dr. Shuang Liu, Dr. Ulrike Dydak, Dr. James Schweitzer 
and Dr. David Hofeldt. Our collaborators Dr. Susan Clare, Dr. Mi-Ran Choi, Dr. Naomi 
Halas, whose foundational work in cancer therapy provided motivation to this research.  
My lab members Justin Sick, Fahed Alsanea, Alison Roth, Michael Schaffer, Bo Liu, Ning 
Cao, Chungwein Lee and Michael Klem. My sincere thanks to the Department of Health 
Sciences at Purdue, particularly Dr. Wei Zheng (Head of Department) and Ms. Karen 
Walker (Graduate Secretary). Lisa Hilliard (Director, Medical Laboratory Sciences) and Dr. 
James Walker (Dept. of Basic Medical Sciences) for contributing to the skull study. The 
funding for this project was provided by Ross Fellowship (Purdue), Purdue Research 
Foundation (PRF) Grant and the Graduate Assistantship provide by the Department of 
Health Sciences at Purdue University.   
 
It would not have been possible to come this far without the love and support 
(emotional and technical) from my parents Dr. Narayan and Dr. Shitala Prabhu Verleker, 
my wife and better-half Shweta, my sister Sayali and brother Ashwin. 
iv 
 
TABLE OF CONTENTS 
Page 
LIST OF TABLES .................................................................................................................. viii 
LIST OF FIGURES .................................................................................................................. ix 
LIST OF ABBREVIATIONS ................................................................................................. xviii 
ABSTRACT .......................................................................................................................... xix 
1 INTRODUCTION ............................................................................................................ 1 
1.1 Overview ........................................................................................................... 1 
1.2 Application in Optically Stimulated Drug Release ............................................ 2 
1.3 Applications Requiring Quantification of NIR Light Delivery ............................ 5 
1.4 Light Transport Theory ..................................................................................... 7 
1.5 A GPU based 3D Monte Carlo for photon transport ...................................... 10 
1.6 An Empirical Photon Propagation Algorithm ................................................. 12 
1.7 A Titanium Dioxide based Optical Dosimetry Probe ...................................... 13 
2 SPECIFIC AIMS ............................................................................................................ 15 
2.1 Specific Aim1: Develop, build and test an optical dosimetry probe and 
advance 3D Monte Carlo photon transport code capable of measuring and simulating 
the local photon fluence and dose in optical tissue phantoms ................................... 16 
2.2 Specific Aim2: Simulate and validate the absolute photon fluence in 
homogenous and heterogeneous brain tissue phantoms resembling white matter, 
gray matter, skull bone and tumor. ............................................................................. 17 
2.3 Specific Aim3: Devise an empirical model and algorithms capable of 




2.4 Specific Aim4: Investigate the feasibility of using the above tools and 
methods to optimize optical therapeutic protocols in human skull bones using image-
guided techniques ........................................................................................................ 18 
3 SPECIFIC AIM1: OPTICAL SIMULATION AND DOSIMETRY TOOLS .............................. 19 
3.1 Introduction .................................................................................................... 19 
3.1.1 Monte Carlo Algorithm ............................................................................... 19 
3.1.2 Optical Dosimetry Probe ............................................................................. 23 
3.2 Materials and Methods .................................................................................. 26 
3.2.1 Monte Carlo Beam Optimization ................................................................ 26 
3.2.2 Optical Dosimetry Probe Design and Calibration ....................................... 29 
3.3 Results ............................................................................................................. 35 
3.3.1 Monte Carlo Optimization .......................................................................... 35 
3.3.2 Optical Probe Calibration ............................................................................ 36 
3.4 Discussion ....................................................................................................... 42 
4 SPECIFIC AIM2: VALIDATION OF MONTE CARLO IN TISSUE PHANTOMS .................. 44 
4.1 Introduction .................................................................................................... 44 
4.1.1 Optical Phantom Characteristics ................................................................ 44 
4.1.2 Spectro-photometer Calibration ................................................................ 45 
4.1.3 Probe and Monte Carlo based validation of intralipid ............................... 48 
4.2 Materials and Methods .................................................................................. 48 
4.2.1 Characterization of Optical Phantoms ........................................................ 48 
4.2.2 Validation of 3D Monte Carlo in brain phantoms using Optical dosimetry 53 
4.3 Results ............................................................................................................. 55 
4.3.1 Optical Dosimetry and Monte Carlo Validation in Homogeneous Phantoms
 55 
4.3.2 Optical Dosimetry and Monte Carlo Validation in Heterogeneous Brain 
Phantoms ................................................................................................................... 62 




5 SPECIFIC AIM3: EMPIRICAL APPROACH TO PHOTON PROPAGATION ....................... 66 
5.1 Introduction .................................................................................................... 66 
5.2 Materials and Methods .................................................................................. 69 
5.2.1 Algorithm Design......................................................................................... 69 
5.2.2 Optimization of the Empirical Algorithm using Monte Carlo ..................... 74 
5.3 Results ............................................................................................................. 75 
5.3.1 Empirical Optimization results .................................................................... 75 
5.3.2 Empirical Validation using Dosimetry Probe .............................................. 82 
5.3.3 Simulations in Head Phantoms ................................................................... 84 
5.3.4 Simulating Fluence Buildup......................................................................... 93 
5.4 Discussion ....................................................................................................... 96 
6 SPECIFIC AIM4: IMAGE-GUIDED OPTICAL TRANSMISSION STUDIES IN HUMAN SKULL 
BONES ............................................................................................................................... 98 
6.1 Introduction .................................................................................................... 98 
6.2 Materials and Methods ................................................................................ 100 
6.2.1 Optical Bone Dosimetry Setup .................................................................. 100 
6.2.2 Acquisition and Processing of CT Images of the Skull Bone ..................... 103 
6.3 Results ........................................................................................................... 105 
6.3.1 Optical Transmission Measurements in the Skull ..................................... 105 
6.3.2 Comparison with the Monte Carlo ........................................................... 110 
6.4 Discussion ..................................................................................................... 116 
7 DISCUSSION ............................................................................................................. 119 
7.1 Design and Calibration of Optical Dosimetry Probe ..................................... 119 
7.2 Dosimetric Validation of a Monte Carlo based Optical Planning tool .......... 120 
7.3 An Empirical algorithm for preliminary optical dose planning .................... 121 
7.4 Image guided transmission studies in skull bone phantoms ....................... 123 
8 FUTURE WORK ......................................................................................................... 125 





Appendix A Validating Scattering Coefficient of Intralipid through Probe 
Measurements ........................................................................................................... 147 
Appendix B Optical Dosimetry in a Goat Skull Phantom ...................................... 149 




LIST OF TABLES 
Table .............................................................................................................................. Page 
Table 4.1 Optical Properties of Brain Tissues [79, 80] ...................................................... 52 
Table 4.2 Phantom Composition [63] ............................................................................... 53 
Table 4.3 % Mismatch Error in Homogeneous Phantom along beam axis (z) .................. 60 
Table 4.4 % Mismatch Error in Homogeneous Phantom perpendicular to beam axis (z) 61 
Table 4.5 % Mismatch Error in Heterogeneous Phantom along beam axis (z) ................ 63 
Table 4.6 % Mismatch Error in Heterogeneous Phantom perpendicular to beam axis (z)
........................................................................................................................................... 63 
Table 5.1 Weights derived for Brain Tissue Phantoms [63] ............................................. 76 
Table 5.2 Weights derived for Brain Tissues ..................................................................... 77 
Table 5.3 Weights derived to obtain fluence buildup ...................................................... 96 
Table 6.1 Optical properties of skull bone measured at 800nm wavelength in different 
studies [80, 100-102]. The anisotropy factor (g) is 0.9. .................................................... 99 
Table 7.1 Optical dosimetry probe composition (diameter<2mm) and % isotropicity 
variation [68, 69]. ............................................................................................................ 120 
Table 7.2 Methods for photon propagation [61, 107-111]. Estimated simulation times 




LIST OF FIGURES 
Figure ............................................................................................................................ Page 
Figure 1.1 (a) Light-induced release of DAPI (4',6-diamidino-2-phenylindole) within 
H1299 lung cancer cells. (b) Left:  H1299 lung cancer cells containing DAPI prior to 
illumination and on the right: after NIR exposure. (Input fluence: 1 W/cm2,  NIR 
wavelength: 800 nm, 5 minute exposure duration). No major cytotoxity was observed in 
assay studies post illumination. (c) Macrophages incubated with gold-silica-nanoshells- 
red fluorescent microspheres complexes [8, 9]. Intra-cellular accumulation f these 
fluorescent molecules is seen in the transmission electron micrograph within the 
cytoplasm vacuoles (see arrow 2). (c) Images using fluorescence microscopy indicate 
microsphere accumulation through red fluorescence (580/605 nm) [8, 9]. ...................... 4 
Figure 3.1 Flowchart of the Monte Carlo algorithm for photon propagation [61] .......... 20 
Figure 3.2 Optical dosimetry probe [68]. .......................................................................... 23 
Figure 4.1 Measurement of light transmission in a Spectro-photometer. A fine pencil 
beam of a specific wavelength is transmitted across a sample contained in a glass 
cuvette with a fixed path length. The absorbance of the sample is calculated using Beer 
Lambert’s law [78]. ........................................................................................................... 46
x 
 
Figure ............................................................................................................................ Page 
Figure 4.2 Calibration curve of spectrophotometer measured absorbance versus 
%Concentration of India ink. The error bars represent minimum and maximum 
absorbance. ....................................................................................................................... 50 
Figure 4.3 Intralipid Scattering: Upper figure represent measured values of scattering 
   	
  
         tometer. 
The error bars represent minimum and maximum values. Lower figure shows 
extrapolated values from the linear relationship derived from the measured values. ... 51 
Figure 4.4 Setup for Optical dosimetry in a liquid phantom. The optical dosimetry probe 
is translated within a plexiglas cuvette filled with liquid phantom, and illuminated by an 
NIR source. ........................................................................................................................ 54 
Figure 4.5 Optical dosimetry in white and gray matter phantoms. The photon source 
used is an integrating sphere connected to a pulsating laser source. The graphs show the 
exponential decrease of photon fluence along the beam axis in white and gray matter 
mimicking phantoms. The Monte Carlo generated fluence closely matches the fluence 
measured by the probe. ................................................................................................... 56 
Figure 4.6 Optical dosimetry in white matter, gray matter and skull bone phantoms. The 
photon source used is an optical fiberguide (connected to a pulsating laser source) with 
a super-Gaussian beam distribution. The Monte Carlo generated fluence closely 
matches the fluence measured by the probe. This shows that the Monte Carlo beam 
modeling can be reliably used as a reliable estimator of photon energy distribution in 
tissue phantoms. ............................................................................................................... 57
xi 
 
Figure ............................................................................................................................ Page 
Figure 4.7 Lateral beam profile measurement using optical dosimetry probe and 
validation by Monte Carlo in homogeneous phantoms. (A) Beam profile in air using 
calorimeter. Optical dosimetry measurements validated MC simulated lateral beam 
profiles in phantoms of: (B) white matter, (C) gray matter and (D) skull bone, i.e., 
perpendicular to the beam axis. The measurements were normalized along the 
illumination axis. Cuvette dimensions: 5.3cm x 4.6cm x 3.1cm, thickness = 0.4cm. ....... 58 
Figure 4.7 Continued ......................................................................................................... 59 
Figure 4.8 Validation of Monte Carlo in a heterogeneous phantom (1.1cm skull agar, 
1.1cm gray matter agar and 5.9cm white matter liquid). Lateral profile measurements 
(in the white matter phantom solution) are shown on the left while axial comparison is 
on the right. The depth shown by z is the distance from the gray matter agar surface. 
Cuvette dimensions: 9.4cm x 9.4cm x 10.9cm, thickness = 0.3cm. .................................. 63 
Figure 5.1 The Empirical photon propagation [64]: The photons in a voxel is propagated 
to neighboring voxels using scatter weights. ................................................................... 71 
Figure 5.2 Integral or accumulation of fluence in a voxel. [64]. The dorectioonal fluences 
such as forward (If), diagonal upwards (Id), diagonal downwards (Idb) and side (Is), 
eneterig a voxel are weighted and summed using forward (wt1) and diagonal weights 
(wt2). Fluence is redistribution conserved by ensuring that (wt1 + 4 x wt2) = 1. ............ 72
xii 
 
Figure ............................................................................................................................ Page 
Figure 5.3 A)Implementation of the 3D Empirical algorithm using nested loops. Photons 
are propagated in the simulation by iterating over a 3D matrix. The matrix dimensions in 
the x, y, z coordinates are dim1, dim2 and dim3 respectively, while (i, j, k) are (x, y, z) 
coordinates of a voxel in the volume. B) Iterative routine to run the Empirical algorithm. 
In each iteration we check if the sum of the residual fluences are below a certain 
threshold. If the residual fluences are still high, we run the empirical code iteratively to 
ensure that the residual fluences have exited the volume. In our study we use 14 
iterations for the neonatal head simulations, while 1 iteration is sufficient for 
homogeneous phantoms. The iterative rouutine is seen to be more effective for highly 
scattering tissues with a significant amount of back-scatter. .......................................... 73 
Figure 5.3 Continued ......................................................................................................... 74 
Figure 5.4 Optimization phase for Brain Tissue Phantoms. The optical properties of 
phantom materials (India ink and Intralipid) from table 4.2, are used by the MC. A flat 
broad beam (2cm diameter) is simulated using Monte Carlo and the Empirical algorithm 
is optimized to match the Monte Carlo with the identical illumination conditions [63]. 77 
Figure 5.5 Optimization phase for Brain Tissues. The brain tissue properties from table 
4.1 are used by the Monte Carlo. A flat broad beam (2cm diameter) is simulated using 
Monte Carlo and the Empirical algorithm is optimized to match the Monte Carlo with 
the identical illumination conditions. ............................................................................... 78 
Figure 5.6 Lateral Beam profile comparison between Empirical and Monte Carlo for Gray 
Matter tissue. A flat broad beam (2cm diameter) is simulated. ...................................... 79 
xiii 
 
Figure ............................................................................................................................ Page 
Figure 5.7 Lateral Beam profile comparison between Empirical and Monte Carlo for 
White Matter tissue. A flat broad beam (2cm diameter) is simulated. ........................... 80 
Figure 5.8 Lateral Beam profile comparison between Empirical and Monte Carlo for Skull 
Bone tissue. A flat broad beam (2cm diameter) is simulated. ......................................... 81 
Figure 5.9 Lateral Beam profile comparison between Empirical and Monte Carlo for 
Astrocytoma Tumor tissue. A flat broad beam (2cm diameter) is simulated. ................. 82 
Figure 5.10 Comparison of the Empirical algorithm with Monte Carlo and Probe 
measured fluence in brain phantoms resembling white matter, gray matter and skull 
bone. The illumination source used is a super-Gaussian beam, which is emulated by the 
Monte Carlo and the Empirical algorithm. The empirical approach is a close 
approximation of the Monte Carlo and the probe over the range of optical properties of 
brain tissues.  [63]. ............................................................................................................ 84 
Figure 5.11 Simulation of a head phantom for comparing the Empirical and Monte Carlo 
models in heterogeneous brain tissues. ........................................................................... 86 
Figure 5.12 Comparison of photon energy distribution between the Empirical algorithm 
and Monte Carlo in a head phantom, along the beam axis. The illumination source used 
is a uniform beam of 2cm diameter. The plot is from the point where light enters the 
skull bone (refer to figure 5.11). ....................................................................................... 87
xiv 
 
Figure ............................................................................................................................ Page 
Figure 5.13 Comparison of photon fluence distribution between the Empirical algorithm 
and Monte Carlo in a head phantom, along the beam axis. The illumination source used 
is a uniform beam of 2cm diameter. The plot is from the point where light enters the 
skull bone (refer to figure 5.11). ....................................................................................... 88 
Figure 5.14 Comparison of photon energy distribution images (2D) between the 
Empirical algorithm and Monte Carlo in a normal head phanton. ................................... 89 
Figure 5.15 Simulation of a head phantom with tumor (astrocytoma) for comparing the 
Empirical and Monte Carlo models in heterogeneous brain tissues. ............................... 90 
Figure 5.16 Comparison of photon energy distribution between the Empirical algorithm 
and Monte Carlo in a head phantom with tumor, along the beam axis. The illumination 
source used is a uniform beam of 2cm diameter. The plot is from the point where light 
enters the skull bone (refer to figure 5.15). ..................................................................... 90 
Figure 5.17 Comparison of photon fluence distribution between the Empirical algorithm 
and Monte Carlo in a head phantom with tumor, along the beam axis. The illumination 
source used is a uniform beam of 2cm diameter. The plot is from the point where light 
enters the skull bone (refer to figure 5.15). ..................................................................... 91 
Figure 5.18 Comparison of photon energy distribution images (2D) between the 
Empirical algorithm and Monte Carlo in a head phanton with tumor (astrocytoma). .... 92 
Figure 5.19 Comparison of the buildup fluence buildup between Monte Carlo and 
Empirical Model for White Matter. .................................................................................. 94
xv 
 
Figure ............................................................................................................................ Page 
Figure 5.20 Comparison of the buildup fluence buildup between Monte Carlo and 
Empirical Model for Gray Matter. ..................................................................................... 94 
Figure 5.21 Comparison of the buildup fluence buildup between Monte Carlo and 
Empirical Model for Skull Bone. ........................................................................................ 95 
Figure 5.22 Comparison of the buildup fluence buildup between Monte Carlo and 
Empirical Model for Tumor (Astrocytoma). ...................................................................... 95 
Figure 6.1 Setup to measure the optical transmission of NIR light through the skull bone. 
The source used is an optical fiberguide connected to a laser. The NIR fluence collected 
by the probe tip is carried by an optical fiber to a PIN photodiode circuit, whose 
electrical output is read using an oscilloscope (right). ................................................... 101 
Figure 6.2 Skull bone sample (top portion) used in the experiment. The dosimetry probe 
is also seen. ..................................................................................................................... 102 
Figure 6.3 Optical dosimetry setup for lateral beam profile measurement in skull sample.
......................................................................................................................................... 102 
Figure 6.4 Optical dosimetry setup for lateral beam profile measurement in a skull 
sample.  This shows the illuminatin setup using the optical fiberguide source. ............ 103 
Figure 6.5 The CT image of a skull bone is processed in Matlab to extract the source 
directional vector (A) and in-plane source vector (B) by drawing lines (blue) on the image 
and extracting the end points of the lines to calculate the vectors. The third vector is the 
cross product of these two vectors and is in the plane of the source. .......................... 105
xvi 
 
Figure ............................................................................................................................ Page 
Figure 6.6 Percentage fluence transmitted for phantoms 1-4 measured using the probe 
calorimeter setup. ........................................................................................................... 107 
Figure 6.7 Percentage fluence transmitted for phantoms 6-9 measured using the probe 
calorimeter setup. ........................................................................................................... 108 
Figure 6.8 Percentage fluence transmitted for phantoms 10-11 measured using the 
probe calorimeter setup. ................................................................................................ 109 
Figure 6.9 Skull thicknesses measured across skull samples using CT image data. 
Measurement points: Phantom1 (1-5), Phantom2 (6-10), Phantom3 (11-15), Phantom4 
(16-20), Phantom5 (21-25), Phantom6 (26-30), Phantom7 (31-35), Phantom8 (36-40), 
Phantom9 (41-45), Phantom10 (45-50).......................................................................... 109 
Figure 6.10 Lateral beam profile (fraction transmitted) measured using the dosimetry 
probe in air and water 0.5mm from the inner skull surface. ......................................... 110 
Figure 6.11 MC simulated fluence profiles along beam axis for a homogeneous skull 
medium generated using Monte Carlo simulations for three sets optical properties of 
the skull bone (Ugrynova et al, Pifferi et al, Firbank et al, and Bashkatov et al). A broad 
beam super-Gaussian NIR source (800nm wavelength) was simulated. ....................... 111 
Figure 6.12 MC simulated lateral fluence profiles at different depths (z=0,2,4,6mm) for a 
homogeneous skull medium generated using Monte Carlo simulations for three sets 
optical properties of the skull bone (Ugrynova et al, Pifferi et al, Firbank et al, and 




Figure ............................................................................................................................ Page 
Figure 6.13 Comparison of % transmitted fluence between the calorimeter-probe 
measurements and the Monte Carlo. The error bars in the probe measurements 
represent the maximum and minimum intensities in the 3 averages, while the error bars 
in the Monte Carlo are the minimum and maximum fluences between the 3 optical 
models (see table 6.1). .................................................................................................... 113 
Figure 6.14 Comparison of lateral profiles measured using dosimetry probe with the 
Monte Carlo in water. ..................................................................................................... 114 
Figure 6.15 Boundary conditions simulated using the CT image-guided Monte Carlo. . 115 
Figure 8.1 MC simulation of temporal pulse width versus depth in a heterogeneous head 
phantom (see figure 5.11) for an input pulse 1ns wide. The pulse width was measured 
by calculating the Full Width at Tenth Maximum (FWTM) to analyze the temporal beam 





LIST OF ABBREVIATIONS 
NIR                 Near Infra-red 
MCX               Monte Carlo Extreme (GPU based Monte Carlo by Fang group) 
MC                 Monte Carlo 
GPU               Graphical Processor Unit 
FWHM           Full Width at Half Maximum 
FWTM           Full Width at Tenth Maximum   
OPO               Optical Parametric Oscillator 
ROI                 Region of Interest     
TiO2                Titanium Dioxide   
RMS               Root Mean Square 
CT                   Computed Tomography 
MRI                Magnetic Resonance Imaging              





Prabhu Verleker, Akshay N. Ph.D., Purdue University, August 2016. A Therapeutic 
Protocol for Treatment of Brain Metastasis through Optically Stimulated Drug Release. 
Major Professor: Keith Stantz. 
 
 
Purpose: The long-term goal of this research is to determine the feasibility of using near 
infra-red light to stimulate drug release in metastatic lesions within the brain. In this 
work, we focused on developing the tools needed to quantify and verify photon fluence 
distribution in biological tissue. To accomplish this task, an optical dosimetry probe and 
Monte Carlo based simulation code were fabricated, calibrated and developed to 
predict light transport in heterogeneous tissue phantoms of the skull and brain. 
Empirical model (EM) of photon transport using CT images as input were devised to 
provide real-time calculations capable of being translated to preclinical and clinical 
applications. 
 
Methods and Materials:  A GPU based 3D Monte Carlo code was customized to simulate 
the photon transport within head phantoms consisting of skull bone, white and gray 
matter with differing laser beam properties,  including flat, Gaussian, and super-
Gaussian profiles that are converging, parallel, or diverging. From these simulations, the 
local photon fluence and tissue dosimetric distribution was simulated and validated 
xx 
 
through the implementation of a novel titanium-based optical dosimetry probe with an 
isotropic acceptance and 1.5mm diameter. Empirical models (EM) of photon transport 
were devised and calibrated to MC simulated data to provide 3D fluence and optical 
dosimetric maps in real-time developed around on a voxel-based convolution technique 
Optical transmission studies were performed using human skull bone samples to 
determine the optical transmission characteristics of heterogeneous bone structures 
and the effectiveness of the Monte Carlo in simulating this heterogeneity. These tools 
provide the capability to develop and optimize treatment plans for optimal release of 
pharmaceuticals to metastatic breast cancer in the brain. 
 
Results: At the time of these experiments, the voxel-based CUDA MC code implemented 
and further developed in this study had not been validated by measurement. A novel 
optical dosimetry probe was fabricated and calibrated to measure the absolute photon 
fluence (mW/mm2) in phantoms resembling white matter, gray matter and skull bone 
and compared to 3D Monte Carlo simulated data. The TiO2-based dosimetry probe was 
shown to have superior linearity and isotropicity of response to previous Nylon based 
probes, and was better suited to validate the Monte Carlo using localized 3D 
measurement (< 25% systematic error for white matter, gray matter and skull bone 
phantoms along illumination beam axis up to a depth of 2cm in homogeneous tissue 
and 3.8cm in heterogeneous head phantom). Next, the transport parameters of the 
empirical algorithm was calibrated using the 3D Monte Carlo and EMs and validated by 
xxi 
 
optical dosimetry probe measurements (with error of 10.1% for White Matter, 45.1% 
for Gray Matter and 22.1% for Skull Bone phantoms) along illumination beam axis.  
 
Conclusions: The design and validation of the Monte Carlo, the optical dosimetry probe 
and the Empirical algorithm  increases the clinical feasibility of optical therapeutic 
planning to narrow down the complex possibilities of illumination conditions, further 
compounded by the heterogeneous structure of the brain, such as varying skull 
thicknesses and densities. Our ultimate goal is to design a fast Monte Carlo based 
optical therapeutic protocol to treat brain metastasis. The voxelated nature of the MC 
and EM provides the necessary 3D photon distribution to within 25% error to guide 





The purpose of our research involves the development of optical dosimetry and 
simulation tools to quantify and optimize the delivery of light to brain tissues. We start 
by introducing the concept of optically stimulated drug release for treatment of 
cancerous lesions in the brain. This mode of therapy requires an efficient optical 
planning system to determine the best modes of illumination to target tissues in the 
brain. Such a planning system applies the physics of optical transport to determine the 
photon distribution in complex heterogeneous media characterized by clinical imaging 
methods, such as CT and MRI. Critical is the need to validate these methods in tissue 
phantoms and to determine their accuracy and precision. To realize these ideas into 
planning systems, which require multiple sources and optimization algorithms, require 
fast execution times not afforded by MC codes. An Empirical algorithm can achieve 
these fast simulation speeds. Ultimately, these simulation tools are validated in tissue 




1.2  Application in Optically Stimulated Drug Release 
To date, brain cancer remains a sanctuary for metastasis. Treatment of Central Nervous 
System (CNS) metastasis poses a critical clinical challenge due to limitations in drug 
uptake in the brain (across the blood brain barrier and blood-cerebrospinal fluid barrier) 
and adverse neurotoxic effects of mainstay therapies, such as whole brain radiation 
therapy (WBRT) and stereotactic radiosurgery [1-8]. Recently, receptor targeted therapy 
aided by improved imaging and localized radiotherapy has shown promise in treating 
cancer within the brain. This is particularly true for HER2+ breast cancer metastasis, 
which have poor median survival rates of 2 to 16 months [1-7]. Therefore, Dr. Susan 
Clare, a Surgeon at Northwestern University Robert H Lurie Medical Research Center, 
devised a method where a patient’s macrophages and monocytes are loaded with a 
drug payload, in this case a lapatinib laden nanoparticle, to actively delivery and target 
the metastatic cancer cells. The ‘Trojan Horse’ concept has shown significant promise in 
targeted drug delivery to the brain, with metastatic cells retaining their sensitivity to the 
drug even after its administration [8, 9]. The use of macrophages as drug carriers has 
been proved to be a potentially effective tool because macrophages have been seen to 
comprise up to 70% of volume in cancerous tumors, such as breast cancer [10-13]. The 
quantification of macrophages in different tumor types can be done using mouse 
monoclonal antibody EBM/11 [14, 15], and is an important process in determining the 




This idea was demonstrated by replacing labeling the payload with fluorescent 
molecules and showing uptake and fluorescence in brain metastasis of mice, which was 
published in Cancer Nanotechnology [8, 9]. The long-term goal of this study is to deliver 
lapatinib-gold nanocomplex laden macrophages to brain metastasis and design a 
therapeutic protocol to optically stimulate drug release in target tissues in the brain.  
With the rate and quantity of drug release being directly dependent on the optical 
power delivered, an optical simulation protocol using Monte Carlo simulations can be 
designed to effectively predict the photon distribution and subsequent drug activation 




1.3 Applications Requiring Quantification of NIR Light Delivery  
While the primary purpose of this research was to enable the quantification of photon 
propagation in heterogeneous brain tissues, it can be easily applied to NIR based 
imaging techniques such as Photoacoustic Tomography (PCT), Near Infra-Red 
Spectroscopy (NIRS) and in optical stimulation of neurons in the brain. The use of the 
Monte Carlo and the optical dosimetry probe in absolute quantification of photon 
fluence in tissues can provide the necessary corrections and validation to quantify 
molecular concentrations in vivo and to deliver the necessary photon dose to trigger 
therapeutic effects.  
 
Photoacoustic effect involves the absorption of light energy by a molecule, which leads 
to a thermal heating and volumetric expansion. The generated acoustic wave usually in 
the ultrasound frequency range is proportional to the optical energy absorbed or dose, 
and thus a molecule’s concentration such as hemoglobin and injectable dyes.  This has 
led to both clinical and pre-clinical applications such as breast cancer imaging, small 
animal studies, hemoglobin concentration, oxygen saturation, blood perfusion imaging 
etc. [16-20]. The application of optical Monte Carlo based methods in Photoacoustic 
imaging has shown promising results in improving the estimation of photon propagation 
in complex tissues being imaged [21-26].  
 
Another imaging modality which widely used the penetrating ability of NIR light in 
tissues, particularly in the brain, is NIR Spectroscopy. The NIR Spectroscopy uses a 
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source and a detector placed on the surface of the brain. The light gets transmitted 
through the skull and after undergoing multiple absorption, scattering and refraction 
events, gets measured by another detector placed on the skull surface near the source. 
The changes in blood oxygenation in the brain leads to changes in light absorption and 
can be monitored through the signal detected at various stages of brain activation, 
initially reported by Jobsis in 1977 [27]. It uses a modified Beer-Lambert’s law for high 
scattering brain tissues [28, 29]. This technique was initially used to map brain function 
of cortical tissues in animal and human subjects [30, 31], and later in brain functions of 
intact skulls in human adults [32-36]. Various applications include monitoring 
intracellular physiological processes in the brain cells and in measuring Cerebral Blood 
Flow (CBF) and Cerebral Blood Volume (CBV) [37-40]. Hence the use of Monte Carlo 
estimation methods for complex 3D photon propagation along with the optical 
dosimetry methods can improve the accuracy of the fNRIS measurements by providing 
absolute quantification of photon fluence.    
 
NIR neural stimulation is another method which requires knowledge of the optical dose 
in the brain. The use of pulsed infra-red lasers has been shown to trigger the excitation 
of neurons at a certain optical threshold [41]. This effect has been observed to be 
wavelength dependent and is seen by measuring the compound action potential (CAP) 
linked to Ca+2 ions in neural mitochondria [41].  Various studies in tissues samples and 
in-vivo have been carried out to monitor this effect and measure the electrical activity 
of the brain [42-49]. The use of Monte Carlo methods with wavelength dependent 
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absorption simulation techniques can provide the necessary information to correlate 
the electrical activity in brain tissue, such as the cochlea and neuro-prosthesis. 
 
1.4 Light Transport Theory 
The radiative transport equation describes the propagation of light through media and is 
considered to be more accurate as it takes into account the absorption and scattering of 
light in heterogeneous media [50, 51].  
s. L(r, s) =  ( + )L(r, s) +    p(s, )L(r, )d	
 ,     (1.1) 
where L(r,s) is the radiance (units: W.m-2.sr-1) at position r, in the direction s (unit vector) 
in a medium with an absorption coefficient of a and scattering coefficient of μs. 
Radiance itself is defined as the radiant flux (Watts/sec) emitted, transmitted or 
received by a surface per unit solid angle, per unit projected area [50, 51]. The total 
attenuation coefficient (μt) is the sum of the absorption (μa) and scattering (μs) 
coefficients (units: m-1). Equation 1.6 describes the change in radiance due to absorption 
and scattering out of or into a volume. The differential solid angle d	 is in the direction 
of s’ and p(s,s’) refers to the phase function, which is the probability of a photon 
travelling in direction s’ being scattered into direction s. or characterized by the 
parameter g (anisotropy factor), the cosine average of the phase function: 
g =  p(s, )(s. )d	
 .     (1.2) 
The value of the parameter g describes the scattering, for example forward scatter 
means g=1, isotropic scatter by g=0 and backscatter by g=-1.  
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The radiative transport theory assumes a homogeneous distribution of the scattering 
and absorbing particles in the medium. This assumption and the quantification of the 
scattering and absorption coefficients can help predict the fluence distribution and the 
absorbed energy in the medium. There are several approximations to solving the 
transport equation depending on the type of irradiance (e.g. diffuse or collimated) and 
optical boundary conditions [50, 51]. For depths far from the light source, there are two 
solutions which account for un-scattered transmission and an asymptotic fluence-rate: 
the Beer Lambert’s law and the Diffusion approximation. The Beer Lambert’s law 
describes the transmission of light through a non-scattering medium: 
T = e ,     (1.3) 
where t is the thickness or path-length, T is the fraction of the intensity transmitted 
through the medium and  is the total attenuation coefficient.  
 
A further modification of the Beer’s Law is made to account for two scattered 
components [51]: 
L(r, s) =  L(r, s) +  L(r, s),     (1.4) 
where Lc is the light that did not interaction with tissue while Ld is the part that 
underwent scattering. Thus using this diffuse theory approximation in the RTE equation, 
the fluence can be simplified to [51]: 
(r) =  	 L(r, s)d
 .     (1.5) 
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The diffuse approximation is affected by the ratio of scattering-to-absorption 
coefficients, the tissue distance from the light source, the boundaries and the 
anisotropy factor [52]. A phase function compatible with the diffusion equation is the 
Henyey-Greenstein function (pHG)  [53, 54]:  




 + 1)(, ) ,     (1.6) 
where Pn are the Legendre polynomials. The phase function given by the delta-
Eddington approximation, combines both the diffusion and forward scatter terms, and is 
given by [55]: 
 (, ) = (  ) + (1  ) (, ),    (1.7) 
where f is the forward scatter amount and p1 are the first two terms of the Legendre 
polynomial. The delta-Eddington phase function makes use of the Henyey-Greenstein 
phase function and is found to be ideal for light propagation in tissues. This is done by 
the following substitutions [53, 55]: 


=  g     (1.8) 
(1  g ) =        (1.9) 
 
Thus, the total fluence rate in a material of finite depth is [56] 
(z) =   a exp(kz) + a exp(kz) + aexp ( z),     (1.10) 
where z is the depth and k is approximately equal to !"". This condition is valid only if 
the absorption coefficient is significantly lower than the scattering coefficient. As per 








ke  ake  ae )    (1.11) 
and 




k  ak  ak).     (1.12) 
 
The optical    s),    a), anisotropy 
factor (g)) can be calculated using the total reflectance and transmission. The reduced 
scattering coefficient s’)  !"  #   s) as follows [61, 62]: 
$

 = (1  g)$     (1.13) 
 
For complex heterogeneous tissues, the relation between reflectance, transmission and 
the three optical parameters become complicated. A unique computation method used 
to simulate the random walk of photons across complex heterogeneous media is the 
Monte Carlo based on %s, %a, g, n, and p(s,s’) 
 
1.5 A GPU based 3D Monte Carlo for photon transport 
The Monte Carlo model uses a random number generator to simulate the transport of 
photons in optical media [57-60] based on the absorption coefficient (μa), scattering 
coefficient (μs), anisotropy factor (g) and the index of refraction (n). A 3D voxel based 
Monte Carlo allows simulation of complex geometrical boundaries, with each voxel 
having unique optical properties (μa, μs, g, n) [59] A packet of photons is assigned an 
initial weight and direction, and propagate from one voxel to another, while depositing 
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energy in each voxel based on its absorption coefficient. The photons also scatter within 
voxels after travelling a pre-determined distance based on the scattering coefficient of 
the medium. The new direction of the scattered photon is determined by the anisotropy 
factor (g) which is the cosine of the phase function [57]. Finally, when the weight of the 
photon reaches a pre-determined threshold, it is extinguished. The weights deposited 
by all the photons in each voxel are accumulated to determine the energy deposited, 
while the total number of photons passing through the voxel is its fluence rate 
(photons/mm2.s) [61].  
 
Traditional CPU based Monte Carlo models [57, 59] suffer from slow computation 
speeds, which makes them non-viable for application in clinical settings, especially in 
highly scattering tissues, such as white matter. The GPU based 3D Monte Carlo code 
used in these studies was shown to be 300X faster compared to our previous CPU based 
models [61]. The CUDA acceleration provided by this model helps to achieve complete 
brain simulation of a high fluence broad beam source within hours, as compared to days 
of simulation time using CPU based models [61 - 63]. This model also provides a voxel 
based 3D distribution of photon fluence and energy deposited, and can be coregistered 
with different medical imaging modalities (e.g. CT, MR, Ultrasound, etc.), thus improving 




1.6 An Empirical Photon Propagation Algorithm 
While Monte Carlo is the gold standard for photon propagation, it has long execution 
times even with the acceleration provided by the GPU based models. For high scattering 
tissues, such as white matter and skull bone, the simulation time for a broad beam 
simulation is on the order of several hours (based on beam diameter) in order to 
achieve statistically significant results at depths of more than 2cm [63, 64]. Thus for 
applications involving optical illumination planning for therapy, where multiple 
simulations are required for optimizing light delivery to tissues at 5-8cm in depth with 
complex geometry and heterogeneity, a fast alternate approach is required, particularly 
for protocols requiring multiple beams [63]. We therefore designed an algorithm based 
on an empirical model (EM) that simulates photon propagation in heterogeneous 
voxelated optical media [63, 64]. 
 
The EM algorithm implements a convolution technique where the photon fluence within 
a voxel is the sum of the weighted fluence in neighboring voxels. It simulates photon 
scatter by assigning weights for forward, diagonal, side and back scatter directions [64]. 
The fluence within a voxel is assumed to be made of directional components in the x, y, 
and z directions to emulate the Henyey-Greenstein function. The fluence entering a 
voxel is redistributed into these directional components such that the sum of the 
weights is conserved prior to absorption. The scatter weights are determined by 
comparing the photon fluence distribution with the Monte Carlo under similar 
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illumination and boundary conditions, before being applied to complex heterogeneous 
media [64]. 
 
The Empirical algorithm provides a fast approach to simulate complete 3D simulations 
at a fraction of the time (seconds) compared to the Monte Carlo (hours) in complex 3D 
media (e.g. brain) [63, 64]. This allows us to evaluate multiple illumination conditions for 
an optical therapeutic protocol for optimized light delivery to tissues within clinically 
relevant time frames. The 3D voxel based empirical approach also allows for easy 
integration of the simulated photon energy dose maps with existing imaging modalities,  
e.g., CT, MR, Ultrasound, Photoacoustic Computed Tomography, which improves 
therapeutic planning accuracy [63]. Thus the empirical approach can be used a 
preliminary tool to narrow down the possible illumination conditions, while the Monte 
Carlo can be used to finalize and quantify the estimated fluence for optical therapy. This 
makes the use of optical simulation techniques more attractive in clinical settings by 
reducing the simulation times involved, and is a core purpose of our research.  
 
1.7 A Titanium Dioxide based Optical Dosimetry Probe 
Optical dosimetry involves measuring the localized photon fluence in media such as 
tissues or tissue phantoms. An optical dosimetry probe is a device which consists of a 
bulb of highly scattering material attached to the exposed tip of an optical fiber, with 
the other end of the fiber is connected to a photodiode circuit which is in turn 
connected to an oscilloscope. The light is conducted by the optical fiber to the PIN 
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photodiode where it is converted into an electrical signal. The dosimetry probe is 
preferred over calorimeters due to the smaller size, higher sensitivity, and isotropic 
response of the probe in an aqueous (or liquid) media. In this study, we fabricated an 
optical dosimetry probe with better isotropicity and locality compared to previous 
designs of Nylon based probes. The dosimetry probe was used to validate the fluence 
generated by the Monte Carlo simulation in homogeneous and heterogeneous brain-
tissue phantoms. The optical sensitivity of the probe enabled us to validate extremely 
low fluence in tissue phantoms, unlike the calorimeter.  
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2 SPECIFIC AIMS 
In Chapter 1, quantifying the photon fluence within a heterogeneous tissue is important 
for applications including controlled drug release, neuro-stimulation and therapy, and 
molecular imaging. In each of these applications, quantification of the photon fluence 
and optical dosimetry is critical. Thus, the focus of this research is on the development 
of image-based simulation tools to predict 3D photon distributions within optically 
heterogeneous media and in the advancement of instrumentation to validate these 
techniques. To accomplish these tasks, we propose to:   
 
SA1: Develop, build and test an optical dosimetry probe and advance 3D Monte Carlo 
photon transport code capable of measuring and simulating the local photon fluence 
and dose in optical tissue phantoms; 
 
SA2: Simulate and validate the absolute photon fluence in homogeneous and 




SA3: Devise an empirical model and algorithms capable of simulating for photon 
propagation in complex heterogeneous tissues in real-time; and 
 
SA4: Investigate the feasibility of using the above tools and methods to optimize optical 
therapeutic protocols n human skull bones using image-guided techniques. 
 
2.1 Specific Aim1: Develop, build and test an optical dosimetry probe and advance 3D 
Monte Carlo photon transport code capable of measuring and simulating the local 
photon fluence and dose in optical tissue phantoms 
The rate and quantity of drug release depends on the optical fluence or laser energy 
delivered to the tissues. To measure the photon fluence being delivered, we have 
designed and calibrated an optical dosimetry probe to measure the localized (1mm3) 
photon fluence in tissues with complex optical heterogeneities at depths in brain tissue 
phantoms consistent with preclinical and clinical applications. Next, CUDA based 3D 
Monte Carlo code was further developed to predictor of light fluence/energy 
distribution in tissues. This software has been developed as an open source project by 
the Dr. Fang’s group at Harvard. We have further modified this software package to 
model and simulate 3D photon beams with Gaussian and super-Gaussian distributions 
consistent with the laser beam in our laboratory, along with modifications to increase 




2.2 Specific Aim2: Simulate and validate the absolute photon fluence in homogenous 
and heterogeneous brain tissue phantoms resembling white matter, gray matter, 
skull bone and tumor. 
In order to be used as a therapy planning tool, the 3D Monte Carlo needs to be validated 
in optical phantoms resembling white matter, gray matter and skull bone. The CUDA 
based MC code was used to generate 3D photon fluence and energy absorption (or 
dosimetry) maps generated and validated by optical dosimetry probe measurements in 
homogeneous and heterogeneous brain tissue phantoms. Since the quantity and energy 
threshold of drug released depends on the optical energy coupled to the tissues, the 
cross validation of the dosimetry and simulation tools is a major step in ensuring 
planning accuracy in clinical setting. 
 
2.3 Specific Aim3: Devise an empirical model and algorithms capable of simulating for 
photon propagation in complex heterogeneous tissues in real-time 
Empirical models of photon transport provide an estimate of the local photon fluence in 
heterogeneous tissues with fast execution times for the optimization of clinical 
applications not afforded by Monte Carlo methods. The GPU based Monte Carlo 
requires many hours of execution time to simulate photon distribution within a human 
brain, which can be a disadvantage when optimizing a treatment plan iterating over 
multiple illumination conditions. A weights-based empirical model approach to photon 
propagation is investigated. It simulates photon scatter by using weights for directional 
scatter of photons between neighboring voxels, and absorption using the Beer-
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Lambert’s law. These weights are determined using the Monte Carlo. The objective is to 
achieve execution times on the order of seconds. Thus the empirical approach provides 
an alternative means of evaluating multiple illumination conditions to reduce treatment 
planning time before using the Monte Carlo for final validation of photon fluence and 
provide real-time imaging corrections. 
 
2.4 Specific Aim4: Investigate the feasibility of using the above tools and methods to 
optimize optical therapeutic protocols in human skull bones using image-guided 
techniques  
While dosimetry and simulation studies using optical phantoms helps us  measure of the 
photon distribution in brain tissues under ideal conditions, it does not take into account 
the heterogeneous composition of the skull bone and the bone-tissue interface, which 
affects the optical transmission and distribution of photon fluence within the soft 
tissues.   Computed Tomographic images will be acquired to map the density and 
composition of the bone along with the boundary conditions and to correlate and 
predict the transmission of NIR light through the skull. Experiments will be performed 
on human skull bone samples by mapping out the photon fluence transmitted through 
the bone using the dosimetry probe and comparing it to the Monte Carlo simulated 
photon distribution.  Previous studies have indicated a wide variance in the optical 
properties of the human skull bone, which can be accounted for by the Monte Carlo 
code and optical dosimetry probe measurements developed in this research. Thus, the 
best set of properties for the skull bone for each individual patient can be planned.  
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3 SPECIFIC AIM1: OPTICAL SIMULATION AND DOSIMETRY TOOLS 
3.1 Introduction 
In order to estimate the amount of drug released in tissues, we need to be able to 
derive the number of photons travelling in each voxel (also known as the “fluence”, 
photons/mm2) and the photon energy absorbed per unit volume (mJ/mm3). The photon 
fluence maps can be converted into their corresponding drug release maps by using a 
threshold determined by in vitro studies. We modified a GPU based 3D Monte Carlo 
(MC) to determine the photon fluence in tissues using different illumination beam 
profiles. The validation of the MC software in tissue phantoms requires localized 
measurements of photon fluence in tissue phantoms implementing an optical dosimetry 
probe with isotropic acceptance. In this chapter, we describe the design, fabrication and 
calibration of the probe and the validation of the Monte Carlo through its use. 
 
3.1.1 Monte Carlo Algorithm 
The Monte Carlo method generates a random number between 0 and 1 with a normal 
distribution [57] to determine the step size and photon scatter direction based on the 




where the raw probability is P(r , t) at a position defined by r and at time t. Ea/Et is the 
  	
     	
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a is the absorption coefficient (mm-1) [61].  	 	  
	 	 
and 1 determines the step size or propagation distance of the photon packet between 
		  ! 	 t) given by [57, 59]: 
S1 =  " ln(#) /$%     (3.2) 
which depends on the total attenuation:  
$% =  $& + $'     (3.3) 
In the above equation, $& is the absorption coefficient (mm-1) and $' is the scattering 
coefficient (mm-1). The weight of the photon packet is absorbed within a voxel through 
which it moves based on the pathlength [57, 59, 61]: 
(w = w()*)+)     (3.4) 
,  
    -	 -.  	 
   / 	  -	
exiting the voxel now has a weight of w - /0  
 
The step size is calculated each time a photon enters a new voxel with different optical 
properties. At each interaction site, the new scattering angle (deflection angle) is 
- 	
  	   	
 	
 1 [57] based on the Henyey-
Greenstein scattering function: 
Cos(2) = 345 (1 + g




)  if g < 0     (3.5) 
Cos(2) = =# " 1  if g = 0     (3.6) 
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The anisotropy factor g is the cosine of the phase function with values lying in between -
1 to 1 [57], where g=1 indicates forward scatter, g=-1 implies back scatter, and g=0 


















      (3.9) 
Where x, y, z are the initial (pre-scatter) directional vectors in the x, y, z directions, 
while  ,  ,   are the new or post-scatter directional vectors. Also the azimuthal 
  !"# $ %& '() *%"+,- %. -/%%", *,"/tion and is given by [57]: 
0 = 123     (3.10) 
The Monte Carlo code takes the anisotropy factor along with the values of the index of 
refraction, absorption and scattering coefficients as an input from the user to define the 
optical properties of the medium. The photon energy deposited (or dose) (4567 in 
photons or Joules) in each voxel is given by the product of the photon fluence (F(r8, t) in 
mm-2s or J mm-2s), the absorption coefficient ( 9 in mm-1), the photon pulse duration (or 
illumination time) (:;<= in s) and the volume of the voxel (>?@A in mm3): 




exposed to the TiO2-sphere [63, 68, 69]. This electrical voltage is then read using a 
digital oscilloscope and integrated to obtain a quantifiable measure of the optical 
fluence [63]. 
 
The radiant energy fluence rate at a position “r” is the integral of radiance  (, ) (units 
Wsr-1m2) over all directions (defined by solid angle "") and is given by [68]: 
(r) =  (, 	)
      (3.12) 
where the solid angle about the normal vector  is d. 
The optimal construction of the dosimetry probe is such that the optical fiber is inserted 
a predefined distance within the TiO2 sphere. This prevents a part of the light fluence 
within the probe tip from entering the fiber, thus creating a “blind spot” [68]. This 
requires a correction factor to be applied to the 4 sr solid angle acceptance of an ideal 
dosimetry probe (without a blind spot). The blind spot can be defined in terms of the 
solid angle blind. This correction actor Fb in a probe with fiber diameter d and diameter 
D of the TiO2 sphere (with ""as the arbitrary angles of incidence) is given by [68]: 








     (3.13) 
Thus, 
 9 1 + 
,:
;:     (3.14) 
The fluence passing through the fiber is measured by a flat PIN photodiode, whose 
response Sflat is given by [68]: 
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  =  0cos	
  =  0  


  =  0     (3.15) 
Similarly, for a dosimetry probe, infinitely small, the response to diffuse isotropic 
fluence is given as [68]: 
  =  0	
 =  40  


  =  40     (3.16) 
Thus in order to obtain the true fluence rate entering the probe, we multiply the 






=  ('     (3.17) 
 
Similar to the blind-spot factor, a correction factor accounting for the difference in the 
refractive index of the probe tip and the medium must be applied. The ratio of the 
response of the dosimetry probe in liquids (Fn) relative to air has been studied and 
measured extensively [68] and depends on the difference in the index of refraction 
between the medium and the probe tip. The greater the difference in the refractive 
indices causes a higher fraction of photons to be refracted back into the probe, and 
higher sensitivity, compared to lower differences, e.g. TiO2-epoxy to air versus water. 
The refractive index of the probe (solid) is well above the refractive index of water, thus 
measurements in liquids with higher refractive index gives higher probe sensitivity.      
 
Another potential correction factor, Fi, accounts for inhomogeneity in the construction 
of the spherical probe tip resulting in an anisotropic response [68]. This factor accounts 
for the angular variance in the probe’s response to different incidence angles in the 
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equatorial and azimuthal directions. Excluding the extreme blind spot at oblique angles 
(i.e. from the same direction as where the fiber enters the spherical bulb), the angular 
variance of a well-constructed probe is generally low [63, 70]. In this study, the angular 
response of the dosimetry probes to diffuse incidence fluence was measured to 
determine its isotropicity of response. Thus the reading in air must be corrected to 
obtain the true fluence rate ( ) using the following equation [68]:  
  =       (3.18) 
 
3.2 Materials and Methods 
3.2.1 Monte Carlo Beam Optimization 
The original code of the GPU based 3D Monte Carlo (MC) (by the Fang group [61]) has 
several built-in features to simulate photon sources such as Gaussian, flat beams, pencil 
beams, isotropic point sources, cone beams, etc. The “open source” availability of this 
software and functionality of using random numbers to generate and define photon 
sources allows users to modify the original source code to add additional photon beam 
profiles as used in different optical setups. The CUDA based parallel threading 
functionality also improves the speed of simulation of broad beam sources compared to 
the time consuming nature of simulating multiple pencil beams by calling Monte Carlo 
function separately for each pencil beam. Even though we had used the process of 
generating broad beam profiles, by calling the Monte Carlo serially, in our past studies 
[60]; in this study we have optimized the Monte Carlo to generate broad beams by using 
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the full functionality of the CUDA platform by generating individual pencil beams in 
parallel.  
 
In this study, we modified the original code to simulate a broad beam super-Gaussian 
beam profile emanating from an optical fiberguide, coupled to the output of a Laser-
OPO system (Nd: YAG class 4 laser and a MagicPRISM Optical Parametric Oscillator from 
Opotek Inc., Carlsbad, CA). This profile was measured with a calorimeter (gold standard) 
(Ophir-Spiricon 3A-P-V1) with aperture 12mm, and can be represented with the 
following equation:  
 	
 =  A   e
.()

    (3.19) 
where: 
r =  z tan    (3.20) 
In the above equations, A is the maximum or peak incident energy fluence (J/mm2), z is 
the perpendicular distance from the source to a point along the central axis of the beam, 
 is the divergence angle of the laser   is the standard deviation of the super-
Gaussian lateral beam profile, n is the order of the super-Gaussian distribution. The 
broad beam output of the fiberguide was approximated using multiple single sources 
with super-Gaussian outputs. In our experimental setup, a match in beam profile was 
   !"#   $"%. The radius of the fiberguide source is 0.3cm. Besides the 
super-Gaussian beam from the fiberguide, a flat broad beam with radius equal to the 
output port of the integrating sphere (port radius 0.9cm) was used to characterize the 
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output of the integrating sphere. The beam characteristics were measured using a 
calorimeter (gold standard) and were given as input to the MC code to emulate the 
illumination conditions used in the optical dosimetry setup.  
 
We also added additional functionalities to the Monte Carlo to emit broad beam profiles 
such as converging and diverging beams as emitted when light beams pass through 
convex and concave lenses. This is of particular importance to researchers who wish to 
explore the effect of different beam profiles on photon energy distribution in tissues.  
 
In order to implement the simulation of converging and diverging beams, we allow the 
user to select the beam parameters such as the aperture size (radius) and focal distance, 
e.g., the real or virtual focal length for converging or diverging beams, respectively.  
 
In order to simulate converging and diverging beams, we need to define the angle of the 
photon source vector for each individual pencil beam. We define the emission angle   
for a beamlet as: 
  =   (

)   (3.21) 
where f is the focal depth and r is the radial distance from the center of the aperture of 
the point source (or do you mean beamlet). The parameter r is selected randomly from 
0 to R, where R is the radius of the source aperture. The angle of the photon beamlet 
from this point within the aperture is (	


  ). For a converging beam the initial photon 
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vector is defined by –sin( ) and –cos( ) and for the diverging beam this vector is defined 
by sin( ) and cos(   	
	 	   	    
 .. The 
photon vector directions are then calculated using equations 3.6, 3.7 and 3.8. 
 
3.2.2 Optical Dosimetry Probe Design and Calibration  
Two models optical dosimetry probes constructed with Nylon and Titanium Dioxide 
spherical tips were fabricated and compared, specifically their sensitivity and 
isotropicity of response. 
 
The Nylon spheres have been widely used for photodynamic therapy and were made of 
NylonTM due to their isotropic response [26]. These were used as the standard of 
reference to compare the performance of Titanium based probes. TiO2 probes are 
made from a mixture titanium dioxide (Du Pont Ti-Pure R-900) and a clear two-part 
epoxy (Tra-Con BA-F114) in a ratio of 9.1 mg TiO2 to 1 ml of the epoxy [28, 29]. Titanium 
dioxide was selected due to its particle size of around 410nm [28], which results in 
optimal scattering at 820nm, the wavelength is approximately twice the particle size [28] 
and in the center of the NIR spectrum (700-920nm). Since the wavelength used in our 
studies is 800nm, the titanium probes have been designed to show a higher sensitivity 
than the Nylon probes. The titanium based probe tips were fabricated using a specially 
designed mold [70]. A fiber optic cable (BFL48-400, 4mm diameter, 0.48 numerical 
aperture) was inserted within the cured spheres at a depth of approximately 1/3 of the 




probe is mounted on and rotated by a rotary stepper motor, while keeping the same 
central location of the probe. At each equatorial and azimuthal angle, the probe is 
illuminated by a uniform broad beam of diffuse light formed by laser light (800 nm) 
emanating from an integrating sphere (Melles Griot two port integrating sphere)and its 
response, the output rms voltage, was measured at each angle. The isotropicity is 
measured by calculating the coefficient of variation, the ratio of standard deviation to 
mean of the rms value over all the angles. The range of angles was 0 to 360 degrees for 
equatorial measurements, and 0 to 150 degrees for azimuthal. The angular span for 
Azimuthal measurements was limited due to physical limitations of the setup which 
prevented larger angles due to presence of the integrating sphere. The individual rms 






Note that the probe voltage signal was filtered using a bandpass Butterworth filter to 
remove high frequency noise in the probe response. The photon fluence is proportional 
to integral of the probe voltage output over the time of the laser pulsed. The probe’s 
integral voltage as well as the calorimeter power was normalized to the exposed surface 
areas of these detectors, where the probe (spherical) surface area is 7.065mm2 and the 
calorimeter (circle) surface area of 113.04mm2. 
 
The linear relationship in equation 3.19, used to quantify the photon dose in air, was 
modified to account for the optical fluence in liquid brain phantoms. The light entering 
the dosimetry probe depends on the ratio of the refractive index of the TiO2-expoxy 
sphere to the medium. The refractive index of probe tip lies between the refractive 
indices of titanium dioxide (approximately 2.73) [29] while that of the epoxy (around 
1.53). Since the refractive index of air is smaller than that of water, the probe response 
in water is smaller as more light will escape the probe when placed in water. The 
reflectance factor is 0.41 for the probe-to-air interface (nprobe/nair is 2.5), and 0.74 for 
the probe-to-water (nprobe/nwater is 1.88) [26]. The difference in the refractive index and 
reflectance between probe-air and probe-water interfaces (water and tissue have 
similar refractive index of 1.329) must be accounted for to quantify photon dose in 
water. In order to determine the calibration factor, we measured the probe response in 
air and water within a cuvette illuminated by a diffuse broad uniform beam emanating 
from an integrating sphere (same setup as figure 3). The probe was placed inside the 
  	 
 
  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then measured again by fil   	
   water), without changing the 
position of the probe with respect to the cuvette and the laser source. By accounting for 
the water attenuation (μwater of 0.02cm1 and a path length of 0.2cm) and the difference 
in the beam spread due to change in refractive index, the calibration factor (CF) was 
determined experimentally to be 1.318, using the following equation:  
CF =  





    (3.23) 
  
The difference in the beam spread difference between the cuvette-air setup versus the 
cuvette-water setup is accounted for by multiplying the fluence measured in air with the 
ratio of the measured beam spreads: fwhmair=40mm and fwhmwater=42mm, or a ratio  of 
0.9091.The experimentally derived calibration factor is then used for absolute photon 
quantification by multiplying it to the probe response measured within tissues and 
tissue-like media as follows (from equation 1 and 2):  
()*+,-./0 =  
(123&445')67.89:;
<:=.>;
    (3.24) 
 
w absolute is the absolute dose in mW/mm2 ? tissue is the probe response 
(mV/mm2), which is proportional to fluence measured in the tissue over the surface 




3.3 Results  
3.3.1 Monte Carlo Optimization 
The Monte Carlo software was modified to simulate a super-Gaussian beam profile by 
generated by laser light passing through an optical fiberguide. Figure 3.5 shows the 
lateral fluence profiles generated by the MC and that measured by the calorimeter. 
Modifications were also done to the original MCX software to simulate converging and 
diverging beams, which are shown in figures 3.6 and 3.7. These were added for future 




Figure 3.5 Super-Gaussian beam generated by the Monte Carlo, compared with the 
optical fluence measured using a calorimeter [63]. 
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Figure 3.6 Images of converging, diverging and flat beams generated by the Monte Carlo.  
 
Figure 3.7 shows an MC simulation of three convex lenses with different focal lengths 
and with an aperture of 5mm. The increase in focal distance leads to a widening of the 
focal spot in the z-direction as expected. 
 
3.3.2 Optical Probe Calibration 
The optical dosimetry probe was designed to quantify the localized fluence distribution 
in tissues with a high degree of accuracy. This design was compared with standard 
probes made from Nylon in order to analyze the advantages in linearity and anisotropy 
of the novel probe model. The probe response was then characterized to quantify the 
absolute photon fluence in tissues. This procedure involved the use of filtering to reduce 
the statistical noise in the probe voltage and the determination of probe characteristics 





Figure 3.8 Probe Isotropicity of Titanium v/s Nylon probes. The coefficient of variation 
(standard deviation/average rms voltage) was calculated for probes made of Nylon and 
Titanium. The error bars show the minimum and maximum values of variation in 
individual probe response. The Titanium based probes showed a more isotropic 
response in the equatorial and azimuthal directions. A 1.5mm diameter Titanium probe 
was selected for further dosimetric studies. 
 
Figure 3.9 shows the linearity of response of the 1.5mm Titanium based probe. The 
probe response is linear over a dynamic range of 0.01074mW/mm2 to 
0.031316mW/mm2 as measured by the calorimeter. The standard error (Standard 
 	 
          
measuring multiple probe response in air over distances 10.1 to 18.1cm from the 
fiberguide surface. The error in probe response is 1.695% (standard error = 0.226) and 
the % error in calorimeter readings was 1.1299% (standard error = 0.00495). On the 
other hand, the variation of the laser light emitted from the fiberguide over time was 
approximately 3%. Thus the error due to variation in pulsed optical power of the laser 
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was the major source of error in our measurements. These showed that Titanium 
probes are better suited to optical dosimetry studies, as compared to Nylon probes, and 
were used in brain phantom studies. While Nylon probes have been used before in 




Figure 3.9 Probe linearity: graph of total voltage (area under pulse) (mV/mm2) measured 
by a 1.5mm diameter Titanium probe versus the power measured by a calorimeter per 
unit surface area (mW/mm2). The probe response is linear over a dynamic range of 
1.2mW to 3.5mW as measured by the calorimeter. The error bars represent 3% 
variation in pulsed laser power fluctuation measured by the probe and calorimeter. 
 
The filtering of the probe response reduces the noise in the probe voltage and provides 
a clean signal. The Butterworth filter used can be tuned to optimize the signal to noise 
ratio and removes the high frequency noise in the probe voltage, mainly attributed to 
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electronic noise externally induced in the PIN photodiode circuit. The use of the filtered 
signal also reduces the noise dependency of the measured fluence as we saw that the 
noise variations in the measured signal mainly affected the measured output in the low 
fluence regions, where (S/N) ratio is low. The filtering step (final versus initial signal) is 
shown in figure 3.10. It is clearly seen that the high frequency noise at the periphery of 
the signal is reduced. This can be even reduced further by adjusting the filter 
coefficients, based on the operator’s discretion.  
 
In order to quantify the measured probe voltage, there are several methods which can 
be used. Some commonly measured parameters are the root mean square (RMS) 
voltage, mean voltage and maximum voltage. In our studies we found that the RMS 
voltage is a reliable parameter can be used to quantify the signal. However the RMS 
voltage also depends on the signal noise and can be problematic if the noise level 
changes with photon fluence measured. Thus in order to quantify the photon fluence, 
we used the integral of the voltage (or area under the peak) of the measured signal. This 
quantity can be made independent of the noise level by summing only those voltages 
above a certain noise threshold level. In our studies, we found that a threshold of 5% of 
the maximum value of the measured voltage was sufficiently above the average noise 
variations at the signal periphery. Thus, while RMS value is a quick means to estimate 
the measured fluence, the area under the peak can be a better measure of the absolute 




Figure 3.10 Filtering the response using a Butterworth band-pass filter. The signal to 
noise ratio is significantly improved by using the filter. 
 
In order to calculate the absolute photon fluence in tissues and tissue-like media, the 
probe voltage measured within the medium must be multiplied by the calibration factor 
to account for the change in photon loss in the probe-medium interface with respect to 
the probe-air interface, where the calibration was performed. Since the refractive index 
of tissues is nearly same as that of water, the calibration factor obtained for water can 
be used for biological media. The probe calibration factor was determined to be 1.32. 
The technique presented (using equations 3.22, 3.23, 3.24) provides a simple method to 
determine the calibration factor experimentally, and is a novel addition to our research. 
It is important to note that while equation 3.23 remains same for any probe, the 
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equations 3.22 needs to experimentally determined, so as to derive equation 3.24 for 
absolute photon dose quantification. 
 
3.4 Discussion  
The Monte Carlo code was optimized to emit a super-Gaussian beam profile. Its voxel 
based design allows us to clearly define object boundaries and specific optical 
properties of each voxel in the volume to be simulated, generating a photon fluence 
(units: J.mm-2.s-1 or photons.mm-2.s-1) \ and an absorbed energy (units Joules) map. The 
latter is calculated by multiplying the simulated fluence (J.mm-2.s-1) with the absorption 
coefficient (units mm-1) of the voxel, volume (units: mm3) of the voxel and the length of 
the time period (units: seconds). The 3D voxelated output of the Monte Carlo is can be 
conveniently integrated and analyzed with 3D medical imaging modalities such CT, MR, 
Ultrasound, etc. Thus absolute photon quantification using Monte Carlo has the 
potential to be used for image guided therapy. The reduction in simulation times 
(couple of hours) of the CUDA based Monte Carlo also improves its potential to be 
applied in the clinic for calculating the photon dose in optical based therapies.   
 
We designed an optical dosimetry probe with a linear and isotropic response, and with 
superior sensitivity compared to Nylon probes. These dosimetry probes can now be 
used for in vitro and in vivo studies for localized measurement of the absolute photon 
fluence. The calibration of the dosimetry probes allows us to measure its linearity and 
isotropicity and derive the calibration factors necessary to measure the absolute energy 
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fluence in mW/mm2. The calibration factor (1.32) derived in this study accounts for the 
difference in the sensitivity of the probe in air and water. The other calibration factor is 
the isotropic sensitivity of the probe and depends on the probe orientation. This factor 
gives the % error in probe response based on the azimuthal and equatorial orientation 
of the probe. An average error over all the angles is sufficient to understand the 
variations in measurement based on probe orientation, with the goal of having each 
measurement independent of the probe’s absolute position in the media. More studies 
using goniometric measurements may improve the accuracy of the measurements and 
are recommended before using the probe in a clinical setting. Our study has shown the 
advantages of using Titanium Dioxide probe over traditional probes made of Nylon for 
dosimetry studies for NIR wavelengths of around 800nm. More dosimetry probe 




4 SPECIFIC AIM2: VALIDATION OF MONTE CARLO IN TISSUE PHANTOMS 
4.1 Introduction 
In order to be used as a therapeutic tool, the Monte Carlo software needs to be 
validated. The Titanium Dioxide based optical dosimetry probe, described in the 
previous chapter, allows us to accurately measure photon fluence distribution with 
millimeter resolution,  high sensitivity, and negligible orientation dependencies, , 
compared to previous Nylon-based dosimetry probes. In this chapter we describe the 
design of accurate tissue phantoms of white matter, gray matter, and skull bone used to 
validate the Monte Carlo generated photon fluence. In all these studies, the optical 
dosimetry probe serves as a gold standard photon energy fluence and its uncertainty.. 
 
4.1.1 Optical Phantom Characteristics 
The design of optical phantoms requires an accurate and precise measure of the 
absorption coefficient (µa  	
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matter. Since tissues are made of molecules which scatter and absorb photons, an optical 
tissue phantom is composed of a combination of scattering (e.g. Intralipid, Titanium 
dioxide, Aluminum Oxide, Polymer Microspheres, Quartz Glass Microspheres) and 
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absorbing materials (e.g. India Ink, Molecular dyes such as Indocyanine Green (ICG), 
Fluorophores), each in varying proportion based on their individual absorption and 
scattering properties [73-77]. These absorbers and scatterers are added to water or agar, 
which provides a stabilizing medium for uniform distribution of the absorber and 
scatterer molecules, and defines the refractive index of the resulting phantom. An optical 
phantom should be designed such that its optical properties closely match those of the 
corresponding tissue at the wavelength of interest. This however is a complex problem 
due to the apparent mismatch between “non-absorption” related properties (µs    
absorbers and “non-scattering” related properties (µa     	
	 
		
 	   One way to reduce this complexity is to select materials that 
have closely matching g and n values to tissue (water and agar), a pure scattering media 
with negligible absorption properties, and a pure absorber with negligible scattering 
properties, while allowing uniform mixing of absorber and scatterer molecules [73].  
 
4.1.2 Spectro-photometer Calibration  
In this study, intralipid was used as a scatter and India ink as an absorber in 
concentrations that resemble the optical properties of white matter, gray matter and skull 
bone. For each tissue type used in the brain phantom, the absorption coefficient of India 
ink and scattering coefficient of intralipid were determined using a spectro-photometer 
which served as the gold standard to measure absorption and scattering properties. While 
absorption properties of India ink (units: %Concentration-1cm-1) vary from batch to batch 
in commercially available samples, the variation in the scattering properties 




For a purely absorbing medium the absorbance measured by the spectrophotometer is 
related to the absorption coefficient of the medium by: 




    (4.2) 
where “loge” is the natural logarithm. Similarly the scattering coefficient of a medium 
with a low concentration of scatterers can also be derived from the absorbance 
measurement of the spectro-photometer:  




    (4.3) 
 
Equation 4.3 is true only if the transmitted light intensity is collimated, does not 
undergo multiple scattering events and if the detector aperture is very small [76]. This 
places restrictions on the range of concentrations across which the scattering properties 
can be measured using the spectro-photometer. In this study we validated the 
scattering properties of the intralipid medium across extremely low concentrations 
using probe measurements as well as by comparing to past studies. Past studies by Van 
Staveren [76] have measured the optical properties of intralipid, which can be derived 
using the equations [76]: 
 () =  0.016.    (4.4) 
and 
g() =  1.1  0.    (4.5) 
where  is in micrometers (0.4<  <1.1) and the scattering coefficient  () is in mL
-
1.L.mm-1. This yields an anisotropy factor of g() = 0.636 and a reduced scattering 
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coefficient of 9.95 (%Concentration)-1.cm-1 at   = 800 nm. In this study we have used the 
anisotropy factor derived from equation 4.5 and will compare the scattering properties 
of intralipid to those obtained through equation 4.4.  
 
4.1.3 Probe and Monte Carlo based validation of intralipid  
To further verify the optical properties of intralipid solutions, we did another study using 
the dosimetry probe to measure the extinction coefficient of intralipid solutions. The 
extinction coefficient derived by the probe measurements were then matched by the 
Monte Carlo. The corresponding scattering coefficients which showed the best match to 
data were selected as the true values for that concentration. This additional study cross 
validates the spectro-photometer studies [76] shown by equation 4.4. The reasoning 
behind this study was to be absolutely sure that the scattering coefficient per unit 
volume of the 20% intralipid samples used in our studies were of the same property as 
the 10% intralipid samples used by the Van Staveren study.  
 
4.2 Materials and Methods 
4.2.1 Characterization of Optical Phantoms 
Optical brain phantoms were designed to emulate the absorption and reduced scattering 
coefficients of white matter, gray matter and skull bone at 800nm [79, 80]. Previous 
studies have shown that reliable optical phantoms can be built using India ink (absorber) 
and intralipid (scatterer) [74 – 77] , in addition to the optical absorption by water 




The absorption coefficient of India ink (Higgins non water proof black ink) and the 
scattering coefficient of intralipid (Intralipid 20% from Fresenius Kabi), at 800nm 
wavelength, was determined and validated using a spectro-photometer (Shimadzu 
UVmini 1240 Spectrophotometer), which served as the gold standard to measure 
absorbance. The scattering properties of intralipid can be determined using the 
spectrophotometer for low concentrations and was found to have the average value of 
9.524 cm 1 %Concentration 1, compared to 9.95 cm 1 %Concentration 1 as shown in past 
studies by Van Staveren [76]. Figures 4.2 and 4.3 show the calibration curves of the 
absorbance versus concentration of India ink and Intralipid, and the linear fit was used to 
design optical phantoms that resemble white matter, gray matter and skull bone, similar 
to Van der Zee [79] and Firbank [80]. In Tables 4.1 and 4.2, the measured ex vivo optical 
properties (absorption and scattering coefficients and anisotropy factor) of skull bone, 
gray and white matters and those used in our research studies are shown (the latter 






phantoms comprised of layers of 1% agar doped with India ink and intralipid to 
represent skull bone and gray matter, and topped with a solution of white matter. The 
agar phantom preparation involved boiling a solution of India ink (with predetermined 
concentration) and 1% agar (Fisher Scientific Laboratory Grade Agar A3600-500) in a 
microwave at 95 degree Celsius and adding intralipid to the solution after being stirred 
and cooled to below 45 degrees Celsius. The scattering properties of agar and 
absorption properties of India ink were also measured using a spectrophotometer for 
each individual sample used in the study, while the scattering properties of intralipid 
were derived from the linear relationship in figure 4.3. 
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4.2.2 Validation of 3D Monte Carlo in brain phantoms using Optical dosimetry 
As described in the previous section, liquid optical phantoms, resembling white matter, 
gray matter and skull bone, were designed using predetermined concentrations of India 
ink and Intralipid. The setup for the light dosimetry in the phantoms is shown in figure 
4.4. Two sources of NIR light (an integrating sphere and an optical fiberguide) were used 
to illuminate the phantoms, both of which were connected to the laser source (same 
specifications as used in the calibration process). The dosimetry probe was inserted into 
the phantom and translated using a 3D translation micrometer stage and used to 
measure the optical fluence distribution at various x, y and z locations within the 
phantom. The x, y and z fluence distribution generated by the Monte Carlo was 
compared to the probe measurements to the test the validity and accuracy of the 
Monte Carlo code. The percentage match of the Monte Carlo was calculated relative to 
the probe measurements to estimate the level of confidence of fluence estimation. The % 
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difference between the probe measured fluence and the Monte Carlo was calculated 
both along and perpendicular to the beam axis. 
 
  
Figure 4.4 Setup for Optical dosimetry in a liquid phantom. The optical dosimetry probe 
is translated within a plexiglas cuvette filled with liquid phantom, and illuminated by an 
NIR source. 
 
In order to quantify the photon fluence ( ) in J/cm
2, we converted the output of 
the Monte Carlo fluence ( , photons/mm2) as follows: 




    (4.6) 
where h is Planck’s constant (6.626e-           !
light in the medium. The energy deposited in the tissue is obtained by multiplying the 
photon fluence with the absorption coefficient μa and the volume of the voxel (v): 









4.3.1 Optical Dosimetry and Monte Carlo Validation in Homogeneous Phantoms 
The optical fluence measured by the dosimetry probe in white and gray matter phantoms 
was compared to the Monte Carlo generated fluence. The design of optical phantoms is 
crucial for accurately determining the localized distribution of fluence with the probe 
before validating it using Monte Carlo. Figures 4.5 and 4.6 show the comparison between 
the probe measurements and the Monte Carlo in brain phantoms for two different 
illumination profiles, the flat diffuse beam produced by the integrating sphere and the 
super-Gaussian beam emanating from the optical fiberguide. Comparisons were made 
along the central axis of the beam and in the direction perpendicular to the beam axis at 
different depths, as shown in figure 4.7. These plots reveal the energy fluence measured 






Figure 4.5 Optical dosimetry in white and gray matter phantoms. The photon source 
used is an integrating sphere connected to a pulsating laser source. The graphs show the 
exponential decrease of photon fluence along the beam axis in white and gray matter 
mimicking phantoms. The Monte Carlo generated fluence closely matches the fluence 




Figure 4.6 Optical dosimetry in white matter, gray matter and skull bone phantoms. The 
photon source used is an optical fiberguide (connected to a pulsating laser source) with 
a super-Gaussian beam distribution. The Monte Carlo generated fluence closely 
matches the fluence measured by the probe. This shows that the Monte Carlo beam 






Figure 4.7 Lateral beam profile measurement using optical dosimetry probe and 
validation by Monte Carlo in homogeneous phantoms. (A) Beam profile in air using 
calorimeter. Optical dosimetry measurements validated MC simulated lateral beam 
profiles in phantoms of: (B) white matter, (C) gray matter and (D) skull bone, i.e., 
perpendicular to the beam axis. The measurements were normalized along the 












The average relative % error of the Monte Carlo relative to the probe measurements is 
11.27% for white matter, 13.25% for gray matter and 11.81% for skull bone along the 
beam axis for a range of 0.2-2cm within the phantom, while perpendicular to the beam 
axis, the % relative error is 9.4%, 12.06%, and 8.91% for white matter, gray matter and 
skull bone phantoms. These systematic errors represent the levels of confidence with 
which the Monte Carlo matches the probe measurements, see tables 4.3 and 4.4. 
 
Table 4.3 % Mismatch Error in Homogeneous Phantom along beam axis (z) 
Phantom Error% 
(0.2-1 cm) 
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z=0.8cm   
 Average  
error% 
Skull Bone 
8.41 5.69 12.64   8.91 
 
An analysis of the fluence profile within the skull phantom showed that the super-
Gaussian beam fluence decreases with an effective attenuation coefficient of 4.818cm-1. 
This factor was used to estimate the effectiveness of therapy for different skull 
thicknesses. Based on the validated Monte Carlo method, the power transmitted by the 
fiberguide source for various skull thicknesses are 5.9mW/cm2 (0.4cm thick), 
2.16mW/cm2 (0.6cm thick), 0.83mW/cm2 (0.8cm thick), 0.33mW/cm2 (1cm thick). Thus, 
the % power transmitted in a 1cm thick adult skull is 1.8%, while a pediatric skull of 
0.4cm thickness would allow 33.5% optical power to reach the soft tissue. The thickness 
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of the skull and its density determines the overall attenuation and hence optical 
planning protocols which can be obtain from a CT scan (see chapter 6). 
 
4.3.2 Optical Dosimetry and Monte Carlo Validation in Heterogeneous Brain Phantoms  
Fluence profiles measured in the white matter solution in the layered heterogeneous 
phantom (1.1 cm skull agar phantom, 1.1 cm gray matter agar phantom, 5.9 cm white 
matter liquid phantom in the said order), showed a good degree of match between the 
Monte Carlo simulated data and the probe measurements, see figure 4.8. The 
exponential decrease in fluence along the beam axis is shown on the right side of figure 
4.8 while the lateral beam profiles at different depths above the gray matter agar 
surface is shown on the left side of this figure. The lateral fluence profiles have been 
normalized to the intensity at a depth of 0.2cm above the gray matter agar surface, 
while the fluence profiles along the beam axis were normalized to the fluence at z = 
0.1cm above the gray matter agar surface. The average systematic error (relative % 
error) between the probe and Monte Carlo fluences is 17.71% along beam axis and 
18.04% perpendicular to the beam axis and is shown in tables 4.5 and 4.6. The validation 
of optical dosimetry results in the complex layered phantom validate that the beam 
spread can be estimated correctly by the Monte Carlo if the optical coefficients of the 




Figure 4.9 Validation of Monte Carlo in a heterogeneous phantom (1.1cm skull agar, 
1.1cm gray matter agar and 5.9cm white matter liquid). Lateral profile measurements 
(in the white matter phantom solution) are shown on the left while axial comparison is 
on the right. The depth shown by z is the distance from the gray matter agar surface. 
Cuvette dimensions: 9.4cm x 9.4cm x 10.9cm, thickness = 0.3cm. 
 
Table 4.5 % Mismatch Error in Heterogeneous Phantom along beam axis (z) 
Phantom Error% 
(0.1-1 cm) 




White Matter (over Skull and 
Gray Matter layers) 2.11 33.32 17.71 
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We validated the 3D Monte Carlo code using the TiO2 based dosimetry probe 
measurements in phantoms resembling white matter, gray matter and skull bone. When 
comparing absolute fluence measurements, the error between MC simulated data and 
measured data was less than 25 percent within these homogeneous tissues. The 
independent characterization of the probes and the optical phantoms using calorimeter 
gold standard and spectrophotometer demonstrated the validity of using the probe as a 
gold standard. Studies were performed for two different types of NIR light sources in 
different optical phantoms, and the ease of photon quantification to absolute dose (in 
mW/mm2 or J/mm2) proves the fidelity of the Monte Carlo as a predictive tool to 
accurately estimate 3D photon energy distribution in complex media. The measurement 
and prediction accuracy can be improved with better instrumentation for probe 
localization and better laser beam positioning setups. The boundary conditions of the 
phantom play a very important role in the Monte Carlo results and need to be simulated 
accurately. This includes the accurate depiction of cuvette/phantom dimensions, 
distance from the source and source dimensions.  
 
This study achieves the first step of designing the tools necessary to validate the NIR 
photon distribution in three dimensions in optical phantoms. By quantifying the energy 
fluence and local deposited dose will allow an accurate depiction of the rate and 
quantity of drug release. Critical to these simulations is the accurate determination of 
the tissue structure and boundaries, which can be determined using imaging modalities 
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such as MRI or CT scan to segment various tissue types and obtain an optical property 




5 SPECIFIC AIM3: EMPIRICAL APPROACH TO PHOTON PROPAGATION 
5.1 Introduction 
Translating an optical planning tool into the clinic requires simulations to be performed 
in time frames that are feasible. Monte Carlo simulations takes a few hours of execution 
time to generate statistically significant number of photons for full brain, and this is for a 
single laser source. Obtaining an optimal optical treatment plan requires dose 
calculations for multiple laser sources and iterations to ensure maximal light delivery to 
the target tissues. Hence, even though the CUDA based platform enhances the speed of 
the Monte Carlo by 300X over CPU based models [61], it still would need to be 
significantly accelerated to be provide treatment plans in a clinical setting. This can be 
accomplished by purchasing a cluster of NVIDEA cards (costly). Instead, this motivated 
us to design an empirical model approach to estimate photon propagation in complex 
heterogeneous tissues, which could have a runtime of less than a minute while 
providing a reasonable level of accuracy [64].  
 
A number of analytical solutions are made to the radiative transport equation, also 
known as the Boltzmann transport equation [82]: 
 .(r, ) + (r) + (r)(r, ) = S(r, ) + (r) 	 (r, 
) p( , 
)d 
    (5.1) 
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In the above equation, S(r, ) is source term and describes the power injected into a 
solid angle defined by   within a unit volume at position r;   is the photon propagation 
unit vector; (r, ) is the radiance energy (units: W.cm2.sr1); r is position vector; 
p( , ) is the phase function and represents the probability of photon scattered from 
direction   to  .  
 
The fluence,(r),  is obtained by summing the energy radiance,(r, ), over all 
directions [82]: 
(r) =  (r, )	 
 .   (5.2) 
 
Solving the radiative transport equation can be solved using finite difference methods 
under certain approximations [82]. One such method is the DANTSYS (diffusion 
accelerated neutral particle transport code system) [82].  
 
The diffusion approximation (P1 approximation) is the most commonly used analytical 
approximation to the radiation and is used widely to calculate fluence in homogeneous 




 + (r, t)  . [D(r, t)] = S(r, t).   (5.3) 
 
The diffusion equation can thus be used to derive the optical fluence in homogeneous 
and heterogeneous tissues by using diffusion synthetic acceleration method (DANTSYS) 
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and employs a corrected diffusion equation to accelerate the convergence of transport 
iterations. The use of the diffusion equation results in under-estimation of fluence in 
media with a high ratio of absorption to scattering coefficients [82, 84]. The Monte Carlo 
method thus remains the only method to accurately simulate photon fluence over a 
wide range of albedos. 
 
In our study, we investigated a voxel-based, nearest neighbor weight based method 
trained using Monte Carlo simulated data. In retrospect, this approach is similar to the 
photon convolution method [85], but uses arbitrary weights to determine photon 
scatter at each location (voxel) in a 3D volume. The absorption of photons in each voxel 
is determined using the Beer Lambert’s law [78] and the optical absorption coefficient. 
The photon dose distribution is simulated in a 3D voxelated format for easy comparison 
and 3D optimization with the Monte Carlo and allows seamless integration with medical 
imaging modalities such CT and MR, used to characterize tissue heterogeneity and 
object boundaries of the medium. The empirical nature of this software can be easily 
adapted to different optical properties and voxel sizes by adjusting the scattering 
weights, while the absorption coefficient remains unchanged. As with the MC code, 
different beam profiles and upstream optics can be seamlessly integrated to improve its 
applicability. Realization into CUDA can provide corrective algorithms on the order of a 




5.2 Materials and Methods 
5.2.1 Algorithm Design 
The Empirical approach is based on the assumption that the photon fluence in a voxel in 
a particular layer is a weighted sum of the fluences of neighboring voxels in the previous 
layer [63, 64]. The basic concept and schematic of this algorithm is illustrated in figures 
5.1-5.3. The steps of the algorithm can be summarized as follows: 
1. Assign the incident photon beam distribution (e.g. super-Gaussian beam) to the first 
layer of voxels. In this case, we assume that the direction of photon propagation is in 
the +z direction. 
2. For every voxel in a layer, calculate the directional scatter components. The 
equation 8 represents an example of how the forward scatter component is 
calculated. The coordinates i, j, k denote the x, y and z location of the voxel. The 
arbitrary weights wt1 and wt2 are forward and diagonal weights, which determine 
the percentage of scatter. The sum of all weights is always equal to one (i.e. 
wt1+4*wt2=1), so that the total fluence entering a voxel is equal to the sum of 
fluence absorbed and exiting the voxel. The equations used to calculate the other 
components can be similarly determined. The sum of all the scatter components in a 
voxel equals the total fluence in that voxel (arbitrary units: photons/unit volume). 
3. Calculate absorbed energy (Iabs) using Beer Lambert’s law for a path length dl = voxel 
length, based on the absorption coefficient (μa) of the voxel: 
 (i, j, k) = I(i, j, k)(1  	
)    (5.4) 
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4. Calculate and accumulate the fluence over all voxels in the current layer and 
increment z to proceed to the next layer. Continue propagation till the fluence exits 
the volume. 
 
An example of the implementation of this algorithm in 3D matrices using nested “for 
loops” is shown in figure 5.3 (A). The purpose of this flowchart is to explain the details of 
the algorithm from the perspective of its implementation. Different iterating loops and 
several different data structures are possible to implement this algorithm based on the 
memory and performance requirements.  
 
We implemented an iterative routine, shown in figure 5.3 (B), in order to ensure that 
residual fluences exit the 3D volume. The rationale behind this step is that some side-
scatter and back-scatter components are significantly high in media with high scattering 
coefficients (e.g. white matter). While the software is implemented in the form of a 
primarily forward propagation direction, it leaves behind residual fluence components 
which do not contribute to the total fluence and which do not exit the volume. Thus in 
order to ensure that all residual photons leave the volume, we implemented an iterative 
routine to propagate photons in the forward (+z) and reverse (-z) directions alternatively. 
This was implemented in an iterative fashion. In the first iteration we propagate the 
photons in the +z direction while in the next iteration the matrices are flipped (along the 
x, y, z planes) such that +z direction now refers to the –z, +x refers to the –y and +x 
refers to the –x directions. In other words the matrix is turned upside down. The 
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empirical code is run again (without any additional input fluence) such that the iteration 
is mainly in a direction opposite to the first iteration. We again flip the matrix to its 
original orientation before running the empirical iteration. This is continued until we 
ensure that most photons have exited the volume and the residual fluences are below a 
certain threshold. In our study we found that 14 iterations were sufficient to ensure that 
most photons have exited the volume. It is important to note that the iterative routine 
mainly ensures a better match with Monte Carlo in the lateral direction (in xy plane) 
away from the beam axis. The number of iterations has less effect on effective 
attenuation at the center of the beam where most of the fluence is contributed to by 
the forward directional fluence vector.  
 
 
Figure 5.1 The Empirical photon propagation [64]: The photons in a voxel is propagated 




Figure 5.2 Integral or accumulation of fluence in a voxel. [64]. The dorectioonal fluences 
such as forward (If), diagonal upwards (Id), diagonal downwards (Idb) and side (Is), 
eneterig a voxel are weighted and summed using forward (wt1) and diagonal weights 









5.3.1 Empirical Optimization results  
In this section we describe the optimization studies performed on the Empirical 
algorithm. Both these studies were performed separately for brain tissues and tissue 
phantoms, mainly due to the difference in their optical anisotropy factors, which leads 
to subtle changes in fluence distributions. Table 5.1 shows the weights derived for brain 
tissue phantoms (composed of India ink and Intralipid), while table 5.2 shows the 
weights for real brain tissues. The optical properties of brain tissues are shown in table 
4.1 while those of the tissue phantoms are shown in table 4.2. The corresponding 
comparison in fluence profiles along the beam axis is shown by figure 5.4 for brain tissue 
phantoms and by figure 5.5 for real brain tissues. The difference in the properties mainly 
arises from the difference in the anisotropy factor between intralipid and the brain 
tissues. Thus while we have achieved a match in the reduced scattering coefficient 
between the phantoms and the real tissues, the photon distribution varies to some 
extent between tissues and phantoms, as seen by Monte Carlo simulations. Hence we 
trained the Empirical algorithm to match the match the Monte Carlo generated fluence 
separately for both brain tissues and tissue phantoms. The different resultant weights 




We also did a comparison of lateral fluence profiles generated by the Monte Carlo and 
the Empirical and these are shown in figures 5.6 -5.9. While the optimization routine 
used the match in fluence attenuation along the beam axis as the main criteria, we tried 
to see if this translates into a match along the lateral direction at different depths 
(z=2mm, z=5mm, z=10mm, z=15mm) in homogeneous tissues. Our analysis shows that 
the lateral profiles of the Empirical algorithm closely match those of the Monte Carlo 
under similar illumination and boundary conditions.  
 





Wt1 Wt2 R-square 
White Matter 0.1 0.949461 0.012635 0. 99999 
Gray Matter 0.1 0.87469 0.031328 0. 999969 
Skull Bone 0.1 0.914828 0.021293 0. 99979 
White Matter 1 0.474876 0.131281 0. 99992 
Gray Matter 1 0.062097 0.234476 0.999828 










Figure 5.10 shows the comparison between the Monte Carlo, Empirical and Probe 
measurements in brain tissues for broad beam simulations in homogeneous phantoms. 
The weights derived for tissue phantoms are different from tissues. For the tissue 
phantoms, the weights used are from table 5.1. The beam simulated in a super-Gaussian 
beam as described in chapter 4. The super-Gaussian beam can be easily simulated using 
the Empirical as it allows us to set the photon distribution at any voxel. The average 
relative % error between the Empirical and Probe measurements is 10.2% for White 
Matter, 45.2% for Gray Matter and 22.1% for Skull Bone phantoms; while the 
comparison between Empirical and MC is 22.6% for White Matter, 35.8% for Gray 
Matter and 21.9% for Skull Bone phantoms. The probe measurements validate the 





Figure 5.11 Comparison of the Empirical algorithm with Monte Carlo and Probe 
measured fluence in brain phantoms resembling white matter, gray matter and skull 
bone. The illumination source used is a super-Gaussian beam, which is emulated by the 
Monte Carlo and the Empirical algorithm. The empirical approach is a close 
approximation of the Monte Carlo and the probe over the range of optical properties of 
brain tissues.  [63]. 
 
5.3.3 Simulations in Head Phantoms 
We simulated head phantoms to compare the Monte Carlo and Empirical fluence and 
energy distributions. The phantom simulated had the dimensions of a child’s head. The 
simulation studies were done in the presence (figures 5.11 - 5.14) and absence (figures 
5.15 – 5.18) of tumor to study how well the Empirical photon distribution matches the 
Monte Carlo. 2D photon energy maps were also generated and compared. The weights 
used for the simulations were those of real brain tissues as shown in table 5.2. While the 
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Monte Carlo only generates the fluence map, the energy map is derived from the 
fluence map by multiplying the fluence with the absorption coefficient and the volume 
of the voxel. 
 
In the case of the normal head phantom (without tumor) of 100mm diameter, the 
boundary conditions and tissue dimensions are shown in figure 5.11. The skull thickness 
is 4mm; thickness of gray matter is 10mm, while the center of the head is mainly white 
matter with a diameter of 72mm. The phantom is illuminated with a 20mm diameter 
uniform beam (800nm wavelength). Figure 5.12 shows the comparison plot of the 
energy deposition between the Monte Carlo and the Empirical along the beam axis. The 
first point on the plot starts at the point where the light enters the skull tissue (i.e. 
depth=0 in the plot of figure 5.12 corresponds to z=6 along the beam axis in figure 5.11). 
Similarly, figure 5.13 shows the log normalized fluence plot along the beam axis. Both 
the fluence and the energy plots show that the Empirical fluence and energy simulated 
closely follow those of the Monte Carlo within a certain error. The energy distribution 
maps in 2D are shown in figure 5.14. Note that the Monte Carlo generated map suffers 
from extremely low photon fluence at depths larger than 5cm due to low photon 
statistics (restrained by the time for head simulations), while the Empirical algorithm 
does not suffer from this limitation.  
 
We also studied the performance of the Empirical algorithm in a head phantom in the 





Figure 5.13 Comparison of photon energy distribution between the Empirical algorithm 
and Monte Carlo in a head phantom, along the beam axis. The illumination source used 
is a uniform beam of 2cm diameter. The plot is from the point where light enters the 





Figure 5.14 Comparison of photon fluence distribution between the Empirical algorithm 
and Monte Carlo in a head phantom, along the beam axis. The illumination source used 
is a uniform beam of 2cm diameter. The plot is from the point where light enters the 







Figure 5.18 Comparison of photon fluence distribution between the Empirical algorithm 
and Monte Carlo in a head phantom with tumor, along the beam axis. The illumination 
source used is a uniform beam of 2cm diameter. The plot is from the point where light 




5.3.4 Simulating Fluence Buildup 
The effect of fluence buildup is seen in Monte Carlo simulations near the photon source. 
This effect largely depends on the albedo of the optical medium, where  larger albedos  
enhances this buildup effect compared to smaller values and is significant within 1mm 
from the source in brain tissues. . While the Empirical can closely match the Monte 
Carlo over diffusion region, the existing derived weights were inadequate to simulate 
the fluence build up; therefore, a new set of weights were derived. Plots for the best 
possible match in white matter, gray matter, skull bone, and astrocytoma are shown in 
figures 5.19-5.22, respectively, and their corresponding weights are listed in table 5.3. 
While the Empirical model may not exactly match Monte Carlo simulated data for both 
the diffuse and near-source regions at the same time, it can modified to match the MC 
based on the region of interest. One must note that the problem of fluence build occurs 











Wt1 Wt2 R-square 
White Matter 0.1 
0.637486 0.090629 0.995372 
Gray Matter 0.1 0.711962 0.07201 0.999807 




0.1 0.89585 0.026037 0.955473 
 
5.4 Discussion 
In this specific aim, a reasonable accuracy (R-square of 0.999) was achieved between 
the Empirical and the Monte Carlo for homogeneous and heterogeneous brain 
phantoms and validated using the optical dosimetry probe. Overall, the empirical model 
provides an alternate voxel based approach of estimating photon fluence in 3D 
heterogeneous tissues besides the diffusion approximation and Monte Carlo methods. 
Even though it was less accurate compared to Monte Carlo simulated data, (up to 36%% 
error between probe and empirical), the reduction in computation times (8 hours per 
MC simulation versus 4-12 seconds of Empirical simulation), provides a means for 
clinical and preclinical applications, in particular for large data sets and iterative-based 
optimization routines. Similar to the GPU MC code, it is easily integrated with existing 
imaging modalities such as CT and MR due to its voxelated structure. In order to 
simulate fine structural boundaries of brain tissues, we need a fine resolution of around 
1mm, for which the CT dataset becomes very large. For such large datasets, where the 
Monte Carlo cannot be run iteratively (>24 hours execution time), the empirical 
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algorithm can replace the Monte Carlo for preliminary analysis. More study is required 
to investigate the % match due to difference in the optimization routine and the 
dependence of weights on the scattering properties of the medium. Further research is 




6 SPECIFIC AIM4: IMAGE-GUIDED OPTICAL TRANSMISSION STUDIES IN HUMAN SKULL 
BONES 
6.1 Introduction 
The skull forms an optical attenuator (absorber and scatterer) in the transmission of 
near-Infra-red light to the brain. The success of any NIR based imaging or therapeutic 
technique involving the brain depends on an accurate and precise determination of the 
optical transmission properties of the skull.  The skull bone consists of osteocytes and 
calcium deposits in various densities and complex geometries based on different 
anatomical locations in the skull.  Previous studies have looked at the optical 
transmission properties of different tissues [93-99] using collimated laser beams with 
powers ranging from 10mW/cm2 to 25mW/cm2 [93, 94]. These studies included NIR 
transmission through human cadaver skulls [94].  In our study, we used an NIR laser 
source (17.64mW/cm2) with a complex super-Gaussian broad beam profile and 
investigated if a relationship between voxel-based HU and optical attenuation exists. 
Simulated Monte Carlo data was compared to measured beam intensity and distribution 
implementing the TiO2-based optical dosimetry probe. This data was used to investigate 
the relationship between the HU from CT images and the optical attenuation by 
measuring the transmitted NIR light through human cadaver skulls Critical to these 
measurements is the ability to quantify low power fluence transmitted through the skull 
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afforded with the TiO2 optical dosimetry probe compared to the calorimeter used in 
previous bone transmission studies [91, 92]. 
 
To date, studies [80, 100-102] have measured the optical properties of the brain tissues, 
have mapped the heterogeneity and inter-sample variations. The comparison of the 
optical properties of skull bone found in these studies [80, 100-102] is shown in table 6.1. 
It shows a wide variation in the optical properties reported for the human skull bone. A 
comprehensive work by Bashkatov et al. [100] mapped these variations in optical 
properties of the skull bone at different wavelengths. Our aim is to further understand 
this complexity caused by variations in the bone density and bone thickness to map out 
an accurate fluence map of the Monte Carlo in the brain. The use of Computed 
Tomography images provides a 3D map of the heterogeneous bone structure and allows 
us to accurately generate the boundary conditions and density maps using the Monte 
Carlo.  
 
Table 6.1 Optical properties of skull bone measured at 800nm wavelength in different 
studies [80, 100-102]. The anisotropy factor (g) is 0.9. 






Firbank et al. 0.24 18.4 
Bashkatov et al. 0.11 19.48 
Pifferi et al. 0.07 12.5 




6.2 Materials and Methods 
6.2.1 Optical Bone Dosimetry Setup 
10 Different skull bone samples [courtesy: Lisa Hilliard (Medical Laboratory Science 
Program) and Dr. James Walker (Dept. of Basic Medical Sciences)] were used for the 
optical transmission study. The light source consisted of the optical fiberguide (see 
chapter 2) connected to a laser source. The NIR output of the fiberguide was measured 
using a calorimeter to be 19.94mW or (17.64 mW/cm2) at 800nm wavelength. For 
transmission studies, the optical fiberguide was placed against the outer surface of the 
skull bone, such that its aperture was flat against the bone surface, thus providing a 
normal exposure. The fluence transmitted through the bone was measured using the 
TiO2 dosimetry probe by placing it against the inner surface of the skull bone, opposite 
the fiberguide on the other side of the skull, which was ensured by locating the point of 
maximum fluence. The energy fluence for 5 points or locations per skull was acquired, 
and at each location the measurement was repeated three times.  A total of 10 cadaver 
skull bones were measured, which gave a total of 50 measurement data points. The 





Figure 6.2 Skull bone sample (top portion) used in the experiment. The dosimetry probe 
is also seen. 
 
 
Figure 6.3 Optical dosimetry setup for lateral beam profile measurement in skull sample. 




measurement for optical transmission lies on the inner skull boundary on the line while 
lateral profile is measured at 0.5 cm from the inner skull surface.  
 
In order to identify the source voxel for illumination, another line was drawn tangential 
to the skull surface, passing through the intersection point of the bead and the outer 
skull surface as shown in figure 6.5 (B). The cross product of the illumination vector and 
the source tangential vector is the other vector which also lies tangential to the skull 
surface along the z axis [0 0 1]. The source voxels are then identified as those lying on 
the 3D circle defined by the two tangential vectors. The parametric equation used of a 
3D circular disk [103] can be then used to represent the fiberguide source surface as 
described by the two tangential vectors. Thus one can accurately represent any broad 





not used (incomplete CT scan). The optical transmission measurements show a wide 
variation in the optical power transmitted, due to variation in skull thickness and 
(heterogeneity in) bone densities. In order to map the Monte Carlo fluence to the % 
transmission measurements of the probe, we used CT images to determine the optical 
path-length through the bone (i.e. skull thickness in the direction of illumination). The 
skull thicknesses measured using CT images showed different skull thicknesses both 
within and across the skull samples. The measured skull thicknesses from the CT images 
are shown in figure 6.9. We also measured the lateral beam profiles in the skull 
phantoms in air and water as shown in figure 6.10. The measured probe voltage is seen 
to be higher in water compared to air. This is mainly due to the difference in the skull-
medium interface boundary conditions, such as the differences in the refractive indices 













In order to demonstrate the feasibility of using CT image-guided skull boundaries for 
Monte Carlo simulation, we used the CT images to map the heterogeneity in distribution 
of bone voxels along with the geometry of boundaries. Figure 6.14 shows the 
comparison between the lateral fluence profiles (transmitted through the skull 
immersed in water) measured using the probe versus the Monte Carlo.  The boundary 
conditions derived from the CT images is shown in figure 6.15. The fluence profiles were 
normalized to the maximum value measured at a depth of 5mm from the inner surface 
of the skull bone. The results show a close match between the beam spread simulated 
by the Monte Carlo and measured by the probe. This demonstrates the accuracy with 
which the scattering properties of the bone were modelled, along with the CT image 
enhanced boundary conditions. The CT images of the skull sample also show the 
changing Hounsfield CT numbers across the bone which is the result of varying density 
of the bone structure. Thus compared to previous studies, we have used the CT images 
to account for the different optical path lengths along with boundary conditions. We 
have however, not accounted for the varying densities of the bone, which results in 
differences between the probe and the Monte Carlo fluences.   
 
6.4 Discussion 
The optical transmission study demonstrates the difficulties encountered in optical bone 
transmission studies. The Monte Carlo can accurately simulate photon attenuation in 
the skull only when all the optical properties and boundary conditions are simulated 
correctly. While the skull bone has been measured and modelled as a relatively 
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homogeneous medium in optical simulation studies, the use of CT images shows that it 
is far from homogeneous with wide variations in bone densities at different anatomical 
regions and across subjects. This presents a complicated scenario to model the optical 
propagation of photons through the skull.  
 
We demonstrated the accuracy of boundary conditions determined using CT images by 
comparing the lateral profiles between the Monte Carlo and the dosimetry probe. The 
close match between the profiles shows the accuracy of our simulations. Our study thus 
also reduced the error in measuring skull thicknesses using calipers, which so often goes 
unnoticed in complex tissue structure. For example: an error in correctly measuring the 
skull thickness by a millimeter can result in errors of up to 40% in magnitude (seen from 
our MC data in figures 6.11, 6.12), depending on the boundary and illumination 
conditions. Thus any imaging or therapeutic technique needs to reduce the errors due 
to mismatch in the boundary conditions by using an anatomical imaging technique (such 
as CT) which can map different tissue boundaries. 
 
To improve the match between the Monte Carlo and the measured fluence in skull 
models, we hypothesize that using bone density measurement technique such as 
quantitative CT can significantly improve the localization of high scattering bone voxels 
in the skull bone. The mapping of Hounsfield values of CT number can be directly linked 
to the bone density values by imaging bone density phantoms in the CT scanner. This 
would provide volumetric images of bone densities which can be converted (scaled) to 
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the corresponding scattering absorption coefficients. The optical coefficient scaling will 





7.1 Design and Calibration of Optical Dosimetry Probe 
We designed and calibrated an optical dosimetry probe with a linear and isotropic 
response to input photon fluence. While several designs of the dosimetry probe exist in 
the medical optics market, the application of a specific dosimetry probe for an 
application mainly depends on probe sensitivity to the wavelengths of interest. The 
isotropicity of the dosimetry probes used in past studies is shown in table 7.1. The 
choice of the titanium dioxide for the probe was made to achieve maximum sensitivity 
by maximizing scattering near 800nm wavelength through the use of Titanium Dioxide 
(by Du Pont [71]). We were able to prove that the sensitivity as well as the angular 
response of the TiO2 probe is superior to that of the conventional Nylon based probes. 
The next innovative aspect of our study was the determination of absolute photon 
fluence from the probe response. By using the linear relationship between the probe 
and calorimeter responses, along with the experimental derivation of a calibration 
factor for relating probe response in air to that in water, we were able to derive the 
mathematical relationship to absolutely quantify photon fluence in tissues for in-vitro or 
in-vivo studies in the future. This provides a simple technique to quantify probe 
response experimentally for validation purposes.
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Table 7.1 Optical dosimetry probe composition (diameter<2mm) and % isotropicity 
variation [68, 69]. 
Study By: Probe tip material Isotropicity 
Variation % 
Marijnissen et al ArniteTM 11% 
Marijnissen et al NylonTM 11% 
Van Staveren et al Helioseal (dental sealant) 20% 
Our study TiO2 (best probe) 13% 
Our study NylonTM (best probe) 17% 
 
7.2 Dosimetric Validation of a Monte Carlo based Optical Planning tool 
The Monte Carlo based tool for photon dose estimation was successfully optimized and 
validated, using optical dosimetry probe measurements, to study light dose delivery to 
brain tissue phantoms. Past studies have compared the dosimetry probe measurements 
with simpler models (non voxelated) of the Monte Carlo along illumination axis in 
homogeneous phantoms and tissues for simpler (flat or isotropic) beam profiles (flat 
beams) [104-106]. The long computation times (several hours to days) associated with 
the Monte Carlo prevented any rigorous approach for validation across diverse tissues 
and illuminations. To the best of our knowledge, this is the first study which has sought 
to rigorously validate a 3D voxelated GPU based Monte Carlo using dosimetry probe 
measurements both along and perpendicular to the illumination axis, in homogeneous 
and heterogeneous tissue phantoms with independently derived optical properties, and 
using a complex super-Gaussian beam profile. We also validated the Monte Carlo in a 
diffuse beam generated by an integrating sphere, thus proving the flexibility of the 
Monte Carlo in accurately generating different beam profiles.   
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A past validation study [106] had compared the angular radiance with different viewing 
angles using a flat cleaved probe to the Monte Carlo in tissue phantoms. The measured 
versus Monte Carlo fluence showed a % error variation from 0 to 25% (seen from the 
figure 6 plot in the publication) along the beam axis, mainly due to mismatch in optical 
properties. In another study [105], Monte Carlo validation using dosimetry in a dissected 
Pig Bronchus tissue showed higher % mismatch of around 50% at a 4cm depth, with 
measurement error amounting to 15% variation. The other significant part of the error 
was accounted for by the variation in estimation of the tissue optical properties and 
tissue boundaries. This demonstrates the importance of independent validation of 
optical properties of the medium along with an accurate simulation of boundary 
conditions in the Monte Carlo. In this study, the average % error was well within 25% for 
most of our measurements. The acceleration provided by the GPU platform improves 
the applicability of the Monte Carlo by reducing the development time associated with 
iteratively optimizing the accuracy of the boundary and illumination conditions, which 
was difficult to achieve in the CPU based model.   
 
7.3 An Empirical algorithm for preliminary optical dose planning 
The brain is a highly heterogeneous structure and has complex distribution of tissues 
with varying optical properties. In order to target a metastatic site in the brain we need 
to be able to optimize the light delivery to that region in the brain, which requires us to 
analyze multiple light source positions, orientations as well as source illumination 
profiles; all of which affect the path that photons travel through the brain. Since this 
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requires iterative techniques, multiple simulations of photon propagation with different 
illumination conditions require a tool which is faster than the Monte Carlo (run time a 
few hours). Hence an alternative Empirical model with a run time of a few seconds was 
designed as a preliminary investigation tool with a reasonable level of accuracy 
compared to the Monte Carlo in heterogeneous tissues.  
 
The Empirical model is based on the photon convolution algorithm and uses weights to 
simulate photon scatter from one voxel to another. Its 3D voxel based design helps us to 
integrate it with the Monte Carlo along with 3D imaging modalities such as CT and MR. 
The empirical algorithm was iteratively optimized with the Monte Carlo and tested in 
optical phantoms resembling a child’s brain with and without a tumor. We found a 
reasonable degree of match between the Monte Carlo and the Empirical in both 
homogeneous and heterogeneous tissues. The lateral profiles in homogeneous 
phantoms were also compared and were found to match between the two models.  
 
The errors in the Empirical model include boundary conditions which the Empirical in 
not able to simulate as well as the Monte Carlo. Further research is necessary to 
investigate and optimize the Empirical algorithm to make it more accurate in complex 
heterogeneous tissues. Due to its reasonable degree of accuracy, the Empirical 
algorithm can be used as a preliminary investigation tool to narrow down the optimal 
illumination conditions while the Monte Carlo can be the Gold standard for the final 
dose calculation. A comparison of various models used in past studies is shown in table 
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7.2. The Empirical approach performs favorably with its moderate level of accuracy and 
fast execution times with respect to Monte Carlo. 
 
Table 7.2 Methods for photon propagation [61, 107-111]. Estimated simulation times 








Accurate Long execution 
times 
GPU based Monte 
Carlo [61] 








Accurate Complex to solve 
Diffusion 
Approximation 
(DE) [107, 111] 
Few 
seconds 
Accurate only at large 
distances from source, at 
g<0.6 and at higher 
albedos (μs/ μs+ μa) 
Errors at short 
distances from 
source, at g>0.6 and 
at lower albedos 
(μs/ μs+ μa) 
Hybrid model (MC 
+ DE) [109] 
1-3 hours Moderate accuracy (1-2 
std dev) 
Moderate accuracy 





Moderate accuracy Non-analytical 
technique 
 
7.4 Image guided transmission studies in skull bone phantoms 
The NIR transmission study demonstrates the complexities of modelling the optical 
properties of the skull bone. Past studies measuring the NIR transmission through skulls 
had measured the transmission through cadaver skulls with intact soft tissues [93, 94]. 
This resulted in larger uncertainties in the optical properties (with the inclusion of soft 
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tissue). No image based technique was used in these studies to determine the optical 
pathlength through the samples. In this study we measured NIR transmission through 
pure skull bone samples without any soft tissue, and demonstrated the use of image 
guided technique to determine the bone thickness. We also successfully demonstrated 
the close match between the lateral beam profiles measured in water, which shows the 
importance of using image guided techniques to map heterogeneity of the skull. While 
the transmission errors between the Monte Carlo and the probe measurements are 
significant for some measurement points, this study tries to point at the scope for future 
investigation into the heterogeneous density distribution of scatterers in the skull bone. 
There is a need to model the varying optical scattering of the bone based on bone 
density. Methods such as bone densitometry and quantitative CT can be used to 
calculate skull bone densities and can potentially improve the accuracy of the Monte 
Carlo.      
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8 FUTURE WORK 
While this study has looked specifically at building optical dosimetry and photon dose 
simulation tools with an intention of future application in light induced drug activation 
in the brain, we are still some distance away from accurately modelling the drug release 
maps in the brain. This is mainly due to a lack of understanding of the mechanism for 
drug activation. While in vitro experiments as well as in vivo studies in mice have shown 
promising results, the energy threshold for drug release is still uncertain. The drug-
nanocomplex molecule consists of a therapeutic drug molecule (e.g. lapatinib) which is 
complexed with a gold plated silica nanoshell [8]. These nano-complexes are incubated 
in macrophages and monocytes and injected into the blood stream, cross the blood 
brain barrier, and accumulate in the metastatic lesions in the brain [8, 9]. Thus when 
irradiated with an NIR source with sufficiently high power, the high absorption cross-
section of gold nanocomplexes results in heating of the nanoparticles [86, 87] which can 
lead to breakage of bonds binding the drug (or any fluorescent molecule) to the nano-
complex and subsequent release and activation of the drug [8, 9]. The resulting rise in 
temperature has been shown to be around 37.40C as shown in previous studies [86] for 
a power of 4W/cm2. The heating property of the gold nanoshell nano-complex can be 
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tuned by changing the size of the silica nano-shell compared to that of the outer gold 
plated layer [88], which allows us to optimize the drug molecule with respect to the 
wavelength of light delivery.  While this shows significant promise in the mechanism of 
temperature rise leading to drug release, more research needs to be done to 
understand the temperature related dependence of the drug release.  
 
In order to control the rise in temperature in the region surrounding the nanocomplex 
molecules, the instantaneous energy provided to a tissue region can be controlled by 
adjusting the pulse width of the laser beam. The use of pulsed laser beams has been 
shown to improve the instantaneous temperature rise and release in of drug molecules 
tethered to nanoparticles, compared to continuous wave lasers [112]. This will allow 
more instantaneous power to be coupled to the nano-molecules while reducing the 
chances of laser induced adverse tissue heating or denaturing of the drug. The 
maximum energy that can be safely coupled to tissues is limited by the maximum 
permissible exposure (MPE). MPE values are based on the pulse duration and the tissue 
type [113, 114]. For example, if we use a laser beam of 1 ns pulse duration, the MPE to 
the skin is 3.17x107 W cm-2 [113, 114]. Based on our prior Monte Carlo simulations using 
a flat 2cm diameter beam, the amount of power coupled to the soft tissue for 1.1cm 
and 0.2cm thick adult and neonatal skull is 4.3x105 W cm-2 and 1.5x107 W cm-2, 
respectively. Thus, a therapeutic drug molecule needs to be designed such that it can be 
activated at a threshold less than the maximum permissible power coupled to tissues at 
a specific depth. For example, a drug molecule with an energy threshold of 1 Wcm-2 can 
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be released up to a depth of 3.8cm in the white matter of an adult brain (skull thickness 
1.1cm, gray matter thickness 2cm), and up to 4.6cm in a neonatal brain (skull thickness 
0.2cm, gray matter thickness 0.2cm) for a flat beam of 2cm diameter, 1ns temporal 
spread and an input fluence of 3.17x107 W cm-2. This shows that the structure of the 
brain and path lengths through the tissue can significantly impact the fluence coupled 
and the effectiveness of therapy. However, these results demonstrate the feasibility of 
NIR stimulated drug release, in particular for children where 4.6cm is more than half the 
diameter of the brain cavity. 
 
Even though reducing the laser pulse width can enhance drug release without 
denaturing the drug or heating the tissue, it can also significantly impact the 
instantaneous or peak energy fluence within the brain. Multiple scattering in brain 
tissues causes the photons to travel with different optical path-lengths, thus 
simultaneously increasing the pulse width and decreasing the peak power at greater 
depths. Past studies have measured the temporal dispersion of laser beams in scattering 
tissues by using time of flight method with a fast optical detector [115, 116], or by using 
radio frequency (RF) modulated light source by detecting the phase of transmitted light 
[117, 118]. A theoretical basis of calculation of the temporal point spread function is 
also provided by Arridge [115] using the temporal point spread function (TPSF), while 
the TPSF is the “response function (Green’s Function) of the medium to a delta impulse” 
[115]. The Monte Carlo used in this study has the ability to simulate photon pulses with 
user-defined pulse duration. In our MC simulation studies, we calculated the temporal 
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dispersion of a 1ns laser beam by measuring the full width at tenth maximum of the 
laser pulse as it propagated along a circular head phantom (boundary conditions shown 
in figure 5.11). The plot of temporal pulse width to the depth in the tissue is displayed in 
figure 8.1. The pulse width is seen to increase by 4-5 times at depths of 3-5cm. This 
implies a reduction in the fluence per unit time by approximately this same amount. The 
pulse width was measured by calculating the full width at tenth maximum, a quantity 
which determines the pulse duration up to 10% of maximum fluence. Therefore, some 
care must be taken when considering the pulse width in the design of the treatment 
plan. To date, the Monte Carlo can be used to predict this spread to optimize drug 






Figure 8.1 MC simulation of temporal pulse width versus depth in a heterogeneous head 
phantom (see figure 5.11) for an input pulse 1ns wide. The pulse width was measured 
by calculating the Full Width at Tenth Maximum (FWTM) to analyze the temporal beam 
spread.  
 
There is a need to quantify the errors due to variability of brain tissue properties, 
particularly the skull bone between different patients. The skull bone thickness and 
density varies across different anatomical regions of the brain [89]. The optical 
properties of the skull bone are also seen to vary across samples [89], which can result 
in differences between the estimation and delivery of photon fluence to metastatic 
tissue in the brain. Hence the need for using a medical imaging system such as 
Computed Tomography (CT) is necessary to segment tissues in the brain, especially the 
bone-brain interface. In our study the average % error in determining bone thickness 
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measured using versus a scale was 30%. Thus modelling the skull heterogeneity using CT 
images has the potential to reduce simulation errors of up to 73% in the fluence coupled 
to soft tissue in adult brains and up to 20% in neonatal brains with respective skull 
thicknesses of 1.1cm and 0.2 cm.   
 
While the bone-brain interface is clearly visible using CT images, better soft tissue 
contrast is necessary to segment different soft tissues such as white matter, gray matter, 
cerebrospinal fluid and metastatic lesions (if any) in the brain. This is best done using 
Magnetic Resonance Images (e.g. T2-weighted), which are also used as the standard 
imaging protocol to segment metastatic lesions in the brain [90]. The MR images 
however cannot be used to image the bone-brain interface, as bone images of the brain 
are generally poor. Hence there is a need to super-impose and co-register CT and MR 
images of patients about to undergo optical therapy. This would provide a significant 
improvement in brain tissue segmentation over CT-only or MR-only based imaging and 
segmentation methods. The co-registration software (e.g. Gamma Plan [91, 92]) used 
needs to be highly accurate to ensure minimal errors in boundary conditions which need 
to be accurately depicted by the Monte Carlo. Phantom studies to determine image 
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Appendix A Validating Scattering Coefficient of Intralipid through Probe 
Measurements 
In order to validate the scattering properties of the intralipid solution and further 
validate the results from the spectrophotometer based studies, we used the dosimetry 
probe and Monte Carlo to derive the reduced scattering coefficient of the intralipid 
solution. Different concentrations of intralipid were illuminated in Plexiglas cuvette 
using the diffuse broad beam from the integrating sphere (connected to the laser 
source). The fluence was measured by the dosimetry probe along the beam axis for each 
of the solutions. We then used the Monte Carlo to derive the scattering coefficient at 
which the probe measurements match the Monte Carlo along the beam axis for the 
same illumination and boundary conditions. The absorption coefficient of intralipid was 
assumed to be the same as of water and the anisotropy factor of 0.636 was used in the 
Monte Carlo. The results are close to those obtained by the spectrophotometer method 
and are shown in figure 4.  
 
This form of measurement was an additional validation step to the spectrophotometer 
method. This method however needs to be precisely calibrated as additional errors and 
offsets may be caused due to mismatch in boundary conditions as well as small 
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